US6630328B2
(en)
|
1909-07-15 |
2003-10-07 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms
|
USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
US4282325A
(en)
*
|
1971-05-14 |
1981-08-04 |
Syva Company |
Enzyme bound corticosteroids
|
US4046636A
(en)
*
|
1974-06-20 |
1977-09-06 |
Syva Company |
Diazepam enzyme conjugates
|
US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US3905871A
(en)
*
|
1971-05-14 |
1975-09-16 |
Syva Co |
Lactam conjugates to enzymes
|
US4191613A
(en)
*
|
1971-05-14 |
1980-03-04 |
Syva Company |
Malate dehydrogenase conjugates for enzyme immunoassays
|
US4039385A
(en)
*
|
1972-05-08 |
1977-08-02 |
Syva Company |
Cardiac glycoside enzyme conjugates
|
NL171930C
(nl)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
US3966556A
(en)
*
|
1972-11-06 |
1976-06-29 |
Syva Company |
Compounds for enzyme amplification assay methadone analogs
|
US3975237A
(en)
*
|
1972-11-06 |
1976-08-17 |
Syva Company |
Compounds for enzyme amplification assay - - ecgonine analogs
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
US4061466A
(en)
*
|
1974-10-16 |
1977-12-06 |
Ingvar Gosta Holger Sjoholm |
Biologically active composition and the use thereof
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
US4043872A
(en)
*
|
1975-02-20 |
1977-08-23 |
Syva Company |
Polyiodothyronine immunoassay
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4096138A
(en)
*
|
1975-12-08 |
1978-06-20 |
Scherr George H |
Immunological test procedure
|
US4166767A
(en)
*
|
1976-03-25 |
1979-09-04 |
Dainippon Pharmaceutical Co., Ltd. |
Insolubilized antibody
|
JPS5341420A
(en)
*
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
US4098876A
(en)
*
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
US4134792A
(en)
*
|
1976-12-06 |
1979-01-16 |
Miles Laboratories, Inc. |
Specific binding assay with an enzyme modulator as a labeling substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51667A
(en)
*
|
1977-03-16 |
1979-10-31 |
Miles Yeda Ltd |
Immunoassay for the determination of a hapten
|
US4156081A
(en)
*
|
1977-04-15 |
1979-05-22 |
Syva Company |
Theophylline antigens and antibodies
|
IT1114861B
(it)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo
|
FR2422956A1
(fr)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
DE2825650C3
(de)
*
|
1978-06-12 |
1981-02-05 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur Bestimmung des Thyroxin-bindungsindex im Serum
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4376825A
(en)
*
|
1979-05-07 |
1983-03-15 |
Syva Company |
Enzyme amplification compounds for assays for androgens
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
US4391904A
(en)
*
|
1979-12-26 |
1983-07-05 |
Syva Company |
Test strip kits in immunoassays and compositions therein
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
JPS58500874A
(ja)
*
|
1981-06-02 |
1983-05-26 |
エレクトロ−ヌ− クレオニツクス、インコ−ポレ−テツド |
免疫沈殿分析
|
US5703206A
(en)
*
|
1981-09-08 |
1997-12-30 |
Univ Rockefeller |
Macrophage inflammatory protein 2 (MIP-2)
|
US4419453A
(en)
*
|
1981-09-28 |
1983-12-06 |
The Dow Chemical Company |
Immunological agglutination assays with dyed or colored latex and kits
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
ZA841924B
(en)
*
|
1983-07-25 |
1984-10-31 |
Becton Dickinson Co |
Chromogenic tracers for use in an assay
|
EP0154631A4
(en)
*
|
1983-07-27 |
1985-11-25 |
American Hospital Supply Corp |
PROCESS FOR SELECTIVE NITRILE REDUCTION.
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
DE3433652A1
(de)
*
|
1984-09-13 |
1986-03-20 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Immunchemisches messverfahren fuer haptene und proteine
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4786594A
(en)
*
|
1986-05-14 |
1988-11-22 |
Syntex (U.S.A.) Inc. |
Enzyme immunoassay
|
EP0394409B1
(en)
*
|
1988-09-02 |
1997-06-11 |
The Rockefeller University |
Macrophage-derived inflammatory mediator (mip-2)
|
EP0703296B1
(en)
|
1988-09-29 |
1998-07-22 |
Chiron Corporation |
Polynucleotide determination by displacement of a strand on a capture probe
|
CA2031109C
(en)
*
|
1990-07-27 |
1992-01-28 |
Susan J. Danielson |
Ligand analogs for immunoassays derived from dicarboxylic acid oxidation products
|
CA2029006C
(en)
*
|
1990-07-27 |
2001-07-17 |
Michael R. Detty |
Dicarboxylic acid oxidation products
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5268298A
(en)
*
|
1991-04-26 |
1993-12-07 |
Life Technologies, Inc. |
System for delivering oxygen to a cell culture medium
|
JP3183666B2
(ja)
*
|
1991-07-19 |
2001-07-09 |
アツセイ・リサーチ・インコーポレーテツド |
内因性サイトカイン類の測定方法およびキット
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5939524A
(en)
*
|
1991-12-09 |
1999-08-17 |
The Scripps Research Institute |
Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
|
US5624804A
(en)
*
|
1991-12-20 |
1997-04-29 |
The Rockefeller University |
Immunochemical detection of In vivo advanced glycosylation end products
|
US5354692A
(en)
*
|
1992-09-08 |
1994-10-11 |
Pacific Biotech, Inc. |
Analyte detection device including a hydrophobic barrier for improved fluid flow
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US7326535B2
(en)
*
|
1993-09-15 |
2008-02-05 |
Ortho Diagnostic Systems Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
US7060283B1
(en)
|
1992-09-15 |
2006-06-13 |
Ortho Diagnostic Systems, Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US6638905B2
(en)
*
|
1993-06-18 |
2003-10-28 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CFR receptor(s)
|
US6495343B1
(en)
|
1993-06-18 |
2002-12-17 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
US20040259113A1
(en)
*
|
1993-07-22 |
2004-12-23 |
Mayo Foundation For Medical Education And Research, Hybritech Incorporated |
Method for detection of metastatic prostate cancer
|
US5516639A
(en)
*
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
US5684144A
(en)
*
|
1993-07-28 |
1997-11-04 |
University Of North Texas |
Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
|
US6884590B1
(en)
|
1994-02-11 |
2005-04-26 |
Cedars-Sinai Medical Center |
Methods of screening for ulcerative colitis and crohn's disease
|
US5681699A
(en)
*
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
AU699748B2
(en)
*
|
1994-05-10 |
1998-12-10 |
Hybritech Incorporated |
Recombinant HK2 polypeptide
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5589344A
(en)
*
|
1994-06-15 |
1996-12-31 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Test kit and method for competitive specific binding assay
|
CA2196797C
(en)
|
1994-08-12 |
2000-10-10 |
Donna M. Shattuck-Eidens |
In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
|
EP0705902B2
(en)
|
1994-08-12 |
2008-08-06 |
The University of Utah Research Foundation |
Nucleic acid probes comprising a fragment of the 17q-linked breast and ovarian cancer susceptibility gene
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US8236493B2
(en)
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5633149A
(en)
*
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
US7005509B1
(en)
|
1995-02-17 |
2006-02-28 |
Incyte Corporation |
Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
|
US6506553B1
(en)
|
1995-03-30 |
2003-01-14 |
Ortho Diagnostics Systems, Inc. |
Method for diagnosis of Epstein-Barr virus associated disease
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
GB0112226D0
(en)
*
|
2001-05-18 |
2001-07-11 |
Danisco |
Method of improving dough and bread quality
|
AU6113396A
(en)
|
1995-06-14 |
1997-01-15 |
Regents Of The University Of California, The |
Novel high affinity human antibodies to tumor antigens
|
WO1997022689A1
(en)
|
1995-12-18 |
1997-06-26 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US7291463B2
(en)
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
EP1728875A3
(en)
|
1996-02-08 |
2007-05-09 |
Affymetrix, Inc. |
Chip-based speciation and phenotypic characterization of microorganisms
|
JP2000504575A
(ja)
|
1996-02-08 |
2000-04-18 |
アフィメトリックス,インコーポレイテッド |
微生物のチップベースの種分化および表現型特徴付け
|
US6924094B1
(en)
*
|
1996-02-08 |
2005-08-02 |
Affymetrix, Inc. |
Chip-based species identification and phenotypic characterization of microorganisms
|
JP2000507245A
(ja)
*
|
1996-03-22 |
2000-06-13 |
ユニバーシティー オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド |
Porphyromonas gingivalisペプチドを含む免疫原性組成物および方法
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
DE69738868D1
(de)
*
|
1996-05-22 |
2008-09-11 |
Viventia Biotech Inc |
Odieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
AU725065B2
(en)
|
1996-07-08 |
2000-10-05 |
Burstein Technologies, Inc. |
Cleavable signal element device and method
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
AU4055697A
(en)
|
1996-08-16 |
1998-03-06 |
Schering Corporation |
Mammalian cell surface antigens; related reagents
|
WO1998013493A2
(en)
|
1996-09-24 |
1998-04-02 |
Lxr Biotechnology, Inc. |
A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
US6093809A
(en)
*
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
US6610839B1
(en)
*
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
US6808880B2
(en)
*
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
SG94355A1
(en)
*
|
1996-10-01 |
2003-02-18 |
Geron Corp |
Human telomerase catalytic subunit
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
GB9907461D0
(en)
|
1999-03-31 |
1999-05-26 |
King S College London |
Neurite regeneration
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
WO1998021367A1
(en)
|
1996-11-15 |
1998-05-22 |
The Board Of Regents Of The University Of Texas System |
Genetic test for equine severe combined immunodeficiency disease
|
EP1803816A3
(en)
|
1996-12-13 |
2007-09-26 |
Schering Corporation |
Mammalian cell surface antigens; related reagents
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
DK0966533T3
(da)
|
1997-02-07 |
2010-01-04 |
Us Gov Health & Human Serv |
Aktivitetsafhængig neurotrof faktor III (ADNF III).
|
US6268165B1
(en)
|
1997-03-19 |
2001-07-31 |
The Board Of Trustees Of The University Of Arkansas |
Methods for the early diagnosis of ovarian cancer
|
ATE403672T1
(de)
*
|
1997-04-01 |
2008-08-15 |
Theracos Inc |
Oral aktive fraktion der momordica charantia, ihre aktiven peptide und ihre verwendung bei der behandlung des diabetes
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
ES2279572T3
(es)
|
1997-05-07 |
2007-08-16 |
Schering Corporation |
Proteinas receptoras humanas de tipo toll, reactivos y metodos relacionados.
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
US6528271B1
(en)
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
US7541151B2
(en)
|
1997-06-05 |
2009-06-02 |
Duke University |
Single-cell biosensor for the measurement of GPCR ligands in a test sample
|
US6235486B1
(en)
|
1997-06-20 |
2001-05-22 |
Mayo Foundation For Medical Education & Research |
Method for detection of breast cancer
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
CN100391973C
(zh)
|
1997-07-09 |
2008-06-04 |
先灵公司 |
分离树突状细胞膜蛋白基因
|
WO1999002721A1
(en)
|
1997-07-11 |
1999-01-21 |
University Of North Texas |
THE ESCHERICHIA COLI csrB GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF
|
US6723550B1
(en)
*
|
1997-07-15 |
2004-04-20 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US20030157642A1
(en)
*
|
1997-07-15 |
2003-08-21 |
Caldwell Robert M. |
Increasing production of proteins in gram-positive microorganisms
|
US6506579B1
(en)
|
1997-07-15 |
2003-01-14 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms using SecG
|
US6762039B2
(en)
*
|
1997-07-15 |
2004-07-13 |
Genencor International, Inc. |
Bacillus subtillis with an inactivated cysteine protease-1
|
US6521421B1
(en)
|
1997-07-16 |
2003-02-18 |
Genencor International, Inc. |
Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
|
CO4810232A1
(es)
|
1997-07-25 |
1999-06-30 |
Schering Corp |
Citoquinas de mamiferos y sus secuencias codificadoras
|
US6180411B1
(en)
|
1997-08-01 |
2001-01-30 |
The Regents Of The University Of California |
Light-triggered indicators that memorize analyte concentrations
|
WO1999006557A2
(en)
|
1997-08-01 |
1999-02-11 |
Schering Corporation |
Mammalian cell membrane proteins; related reagents
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6521440B1
(en)
*
|
1997-09-15 |
2003-02-18 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6300117B1
(en)
*
|
1997-09-15 |
2001-10-09 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
AU748467B2
(en)
|
1997-10-17 |
2002-06-06 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
GB9724629D0
(en)
*
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Alpha/beta hydrolase-fold enzymes
|
US6316241B1
(en)
*
|
1997-11-20 |
2001-11-13 |
Genencor International, Inc. |
Alpha/beta hydrolase-fold enzymes
|
GB9724627D0
(en)
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Gram positive microorganism formate pathway
|
GB9727470D0
(en)
*
|
1997-12-30 |
1998-02-25 |
Genencor Int Bv |
Proteases from gram positive organisms
|
US6528255B1
(en)
*
|
1997-12-30 |
2003-03-04 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US6465186B1
(en)
*
|
1997-12-30 |
2002-10-15 |
Genecor International, Inc. |
Proteases from gram positive organisms
|
US6599731B1
(en)
*
|
1997-12-30 |
2003-07-29 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US6780609B1
(en)
|
1998-10-23 |
2004-08-24 |
Genome Therapeutics Corporation |
High bone mass gene of 1.1q13.3
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
WO2000018885A1
(en)
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US6596501B2
(en)
|
1998-02-23 |
2003-07-22 |
Fred Hutchinson Cancer Research Center |
Method of diagnosing autoimmune disease
|
US6060260A
(en)
*
|
1998-02-27 |
2000-05-09 |
Dade Behring Inc. |
Methods for reducing adsorption in an assay
|
CN1249226C
(zh)
|
1998-03-04 |
2006-04-05 |
金克克国际有限公司 |
支链淀粉酶的修饰形式
|
CA2323812C
(en)
|
1998-03-20 |
2011-05-10 |
The Curators Of The University Of Missouri |
Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins)
|
US6303081B1
(en)
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
ATE328278T1
(de)
*
|
1998-03-30 |
2006-06-15 |
Orasure Technologies Inc |
Sammelapparat für einschrittigen test von mundflüssigkeiten
|
US8062908B2
(en)
*
|
1999-03-29 |
2011-11-22 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
ATE546544T1
(de)
*
|
1998-03-31 |
2012-03-15 |
Esoterix Genetic Lab Llc |
Verfahren zur diagnose und behandlung von lungenkrebs
|
US7108968B2
(en)
*
|
1998-04-03 |
2006-09-19 |
Affymetrix, Inc. |
Mycobacterial rpoB sequences
|
WO1999053295A1
(en)
|
1998-04-14 |
1999-10-21 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(en)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
EP1097378A2
(en)
*
|
1998-07-21 |
2001-05-09 |
Burstein Laboratories Inc. |
Optical disc-based assay devices and methods
|
DK1098988T4
(da)
|
1998-07-21 |
2007-09-03 |
Danisco |
Födevare
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
WO2000017356A2
(en)
*
|
1998-09-18 |
2000-03-30 |
The Rockefeller University |
Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
|
AU6246199A
(en)
|
1998-09-21 |
2000-04-10 |
Schering Corporation |
Human interleukin-b50, therapeutic uses
|
EP0997476A3
(en)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Antibodies to a mammalian Langerhans cell antigen and their uses
|
NZ511991A
(en)
|
1999-01-11 |
2004-03-26 |
Schering Corp |
Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. uses
|
ATE452181T1
(de)
|
1999-02-04 |
2010-01-15 |
Pluristem Ltd |
Verfahren und vorrichtung zur haltung und expansion von hematopoietischen stammzellen und/oder vorläuferzellen
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
ATE420894T1
(de)
|
1999-03-11 |
2009-01-15 |
Schering Corp |
Cytokine aus säugetieren, verwandte reagenzien und verfahren
|
WO2000070045A1
(en)
|
1999-05-13 |
2000-11-23 |
Medical Research Council |
Ox2 receptor homologs
|
AU5011200A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in hematopoietic cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
CA2374391C
(en)
|
1999-06-01 |
2014-10-28 |
Schering Corporation |
Mammalian receptor proteins; related reagents and methods
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
GB9914210D0
(en)
|
1999-06-17 |
1999-08-18 |
Danisco |
Promoter
|
CN1420933A
(zh)
*
|
1999-06-25 |
2003-05-28 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
应用微器官诱导血管生成的方法
|
US6531130B1
(en)
|
1999-07-06 |
2003-03-11 |
The Board Of Trustees Of The Leland Stanford University |
Treatment of demyelinating autoimmune disease with ordered peptides
|
DE60042827D1
(de)
|
1999-07-30 |
2009-10-08 |
Schering Corp |
Cytokine aus säugetieren und dazugehörende reagenzien
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
EP3184637A1
(en)
|
1999-09-09 |
2017-06-28 |
Merck Sharp & Dohme Corp. |
Mammalian interleukin-12 p40 and interleukin b30 complexes, antibodies, uses in pharmaceutical compositions
|
DE60041821D1
(de)
|
1999-09-24 |
2009-04-30 |
Cybios Llc |
Pluripotent embryonale stammzellen-ähnliche zellen, zusammensetzungen und ihre vervendungen
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7668658B2
(en)
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
AU784258B2
(en)
*
|
1999-11-19 |
2006-03-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspegillus niger beta-glucosidase gene, protein and uses thereof
|
EP2275447A1
(en)
|
1999-11-24 |
2011-01-19 |
Schering Corporation |
Methods of inhibiting metastasis
|
EP2336775A3
(en)
|
1999-12-06 |
2013-03-20 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6544792B1
(en)
|
1999-12-21 |
2003-04-08 |
Genencor International, Inc. |
Production of secreted polypeptides
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
EP1252292A4
(en)
*
|
2000-01-24 |
2004-11-17 |
Univ Ramot |
PLANTS TOLERATING THE STRESS OF THE ENVIRONMENT, METHODS OF MAKING SAME FOR THIS TYPE OF PLANT AND POLYNUCLEOTIDE SEQUENCE USED THEREFOR
|
DE10003734A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Bosch Gmbh Robert |
Detektionsverfahren und -vorrichtung
|
JP4981229B2
(ja)
*
|
2000-02-25 |
2012-07-18 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US7875442B2
(en)
*
|
2000-03-24 |
2011-01-25 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
WO2006053769A1
(en)
|
2004-11-18 |
2006-05-26 |
Eppendorf Array Technologies |
Real-time quantification of multiple targets on a micro-array
|
US8288128B2
(en)
*
|
2004-11-18 |
2012-10-16 |
Eppendorf Array Technologies S.A. |
Real-time quantification of multiple targets on a micro-array
|
US7829313B2
(en)
*
|
2000-03-24 |
2010-11-09 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
CA2404489A1
(en)
|
2000-03-27 |
2001-10-04 |
Technion Research And Development Foundation Ltd. |
Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
EP1274834B1
(en)
|
2000-03-31 |
2010-07-07 |
The Scripps Research Institute |
HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
|
US20030108927A1
(en)
*
|
2000-04-03 |
2003-06-12 |
Kathryn Leishman |
Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
|
SI1274450T1
(sl)
|
2000-04-18 |
2009-04-30 |
Schering Corp |
Medicinske uporabe agonistov in antagonistov IL-174
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
JP5073909B2
(ja)
|
2000-05-10 |
2012-11-14 |
メルク・シャープ・アンド・ドーム・コーポレーション |
哺乳動物レセプタータンパク質;関連する試薬および方法
|
NZ522327A
(en)
|
2000-05-25 |
2004-09-24 |
Schering Corp |
Mammalian DNAX Toll-like receptor protein, DTLR 10, antibodies and medicaments made therefrom and use in treating immunological disorders
|
WO2005000087A2
(en)
*
|
2003-06-03 |
2005-01-06 |
Chiron Corporation |
Gene products differentially expressed in cancerous colon cells and their methods of use ii
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
PT1315519E
(pt)
|
2000-08-08 |
2011-03-17 |
Technion Res & Dev Foundation |
Composições farmacêuticas e métodos úteis para tratamento de cancro e fibrose hepática
|
ATE360640T1
(de)
|
2000-08-08 |
2007-05-15 |
St Jude Childrens Res Hospital |
Gruppe-b streptococcus polypeptide, nukleinsäure, therapeutische zusammensetzungen und impfstoffe davon
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
PT1322755E
(pt)
|
2000-09-08 |
2010-11-19 |
Univ Texas |
Péptidos de direccionamento humanos e de murganho identificados por apresentação em fagos
|
EP1315743B1
(en)
|
2000-09-08 |
2012-11-07 |
Merck Sharp & Dohme Corp. |
Mammalian genes; related reagents and methods
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
DK1356060T3
(da)
*
|
2000-09-18 |
2006-05-01 |
Genencor Int |
Dobbeltarginintranslokation i Bacillus
|
IL155097A0
(en)
*
|
2000-09-28 |
2003-10-31 |
Nanocyte Inc |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
US7163800B2
(en)
*
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US7018812B2
(en)
|
2000-11-03 |
2006-03-28 |
Duke University |
Modified G-protein coupled receptors
|
US20050136431A1
(en)
*
|
2000-11-03 |
2005-06-23 |
Oakley Robert H. |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
MXPA03004325A
(es)
|
2000-11-17 |
2004-01-26 |
Vascular Biogenics Ltd |
Promotores que muestran especificidad celular endotelial y metodos para su uso.
|
IL156015A0
(en)
|
2000-11-24 |
2003-12-23 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
US20030054446A1
(en)
*
|
2000-11-29 |
2003-03-20 |
Weber Bernard H. F. |
Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
|
KR20030067696A
(ko)
|
2000-11-30 |
2003-08-14 |
모렉큐랄 스킨케어 리미티드 |
질병의 진단 및 치료
|
EP1337152A4
(en)
*
|
2000-11-30 |
2004-08-11 |
Yeda Res & Dev |
METHODS OF USING CULTURED T CELLS THAT DO NOT INDUCE HOST Graft Reaction (GVHD) TO TREAT DISEASE
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
GB0101762D0
(en)
*
|
2001-01-23 |
2001-03-07 |
Medical Res Council |
Method
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
EP1385829A4
(en)
*
|
2001-03-12 |
2005-10-19 |
Affymetrix Inc |
NUCLEIC ACID MARKING COMPOUNDS
|
US20030104410A1
(en)
*
|
2001-03-16 |
2003-06-05 |
Affymetrix, Inc. |
Human microarray
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US20030220475A1
(en)
*
|
2001-04-03 |
2003-11-27 |
Fields Howard A. |
Neutralizing immunogenic hev polypepetides
|
AU2002254524A1
(en)
*
|
2001-04-06 |
2002-10-21 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health A |
Use of semenogelin in the diagnosis, prognosis and treatment of cancer
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
EP2163256B1
(en)
|
2001-05-11 |
2015-09-02 |
Ludwig Institute for Cancer Research Ltd. |
Specific binding proteins and uses thereof
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
NZ528260A
(en)
|
2001-05-18 |
2005-09-30 |
Danisco |
Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride
|
DE60229846D1
(de)
|
2001-05-22 |
2008-12-24 |
Merck & Co Inc |
Beta-secretase-substrat und seine verwendung
|
US20090324612A1
(en)
*
|
2001-06-05 |
2009-12-31 |
Kaufman Daniel L |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
WO2002099069A2
(en)
*
|
2001-06-05 |
2002-12-12 |
The Regents Of The University Of California |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
US20070190534A1
(en)
*
|
2001-06-11 |
2007-08-16 |
Genesis Genomics Inc. |
Mitochondrial sites and genes associated with prostate cancer
|
MXPA04000397A
(es)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
WO2003012030A2
(en)
*
|
2001-08-01 |
2003-02-13 |
University Of Utah, Technology Transfer Office |
Isoform-selective inhibitors and activators of pde3 cyclic
|
US20030082596A1
(en)
*
|
2001-08-08 |
2003-05-01 |
Michael Mittmann |
Methods of genetic analysis of probes: test3
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
ATE443259T1
(de)
|
2001-09-20 |
2009-10-15 |
Univ Texas |
Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
|
WO2003028582A2
(en)
*
|
2001-09-28 |
2003-04-10 |
Aspenbio, Inc. |
Bovine pregnancy test
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
EP1439857B1
(en)
|
2001-10-12 |
2009-02-25 |
Schering Corporation |
USE OF BISPECIFIC ANTIBODIES BINDING TO THE ACTIVATING RECEPTOR FcEpsilonRI AND TO THE INHIBITING RECEPTOR OX2Ra (CD200Ra) TO REGULATE IMMUNE RESPONSES
|
DE60237777D1
(de)
|
2001-10-19 |
2010-11-04 |
Vascular Biogenics Ltd |
Etzungen und verfahren zur gezielten herunterregulierung von angiogenese und zur krebstherapie
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
CA2467904C
(en)
|
2001-11-20 |
2009-04-07 |
The Curators Of The University Of Missouri |
Compositions and methods for accurate early pregnancy diagnosis
|
US6952704B2
(en)
*
|
2001-11-26 |
2005-10-04 |
Microsoft Corporation |
Extending a directory schema independent of schema modification
|
WO2003048298A2
(en)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
WO2003054155A2
(en)
*
|
2001-12-19 |
2003-07-03 |
Bristol-Myers Squibb Company |
Pichia pastoris formate dehydrogenase and uses therefor
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
US7341844B2
(en)
*
|
2002-01-16 |
2008-03-11 |
Regents Of The University Of Minnesota |
Methods for diagnosing autism
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
EP2371861B1
(en)
|
2002-01-25 |
2017-08-09 |
Novo Nordisk A/S |
Monoclonal antibodies against extracellular loops of C5aR
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
EP2311869B2
(en)
|
2002-02-01 |
2020-06-17 |
Merck Sharp & Dohme Corp. |
Use of mammalian cytokine-related reagents
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
WO2003070752A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
AU2003225589A1
(en)
|
2002-02-22 |
2003-09-09 |
The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And |
Brother of the regulator of imprinted sites (boris)
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
AU2003214614B2
(en)
*
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
US20030182669A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Rockman Howard A. |
Phosphoinositide 3-kinase mediated inhibition of GPCRs
|
WO2003079967A2
(en)
*
|
2002-03-26 |
2003-10-02 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
CA2391438A1
(en)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Psp94 diagnostic reagents and assays
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
WO2003093296A2
(en)
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
WO2003101386A2
(en)
|
2002-05-30 |
2003-12-11 |
Memorial Sloan-Kettering Cancer Center |
Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
|
CA2492631C
(en)
*
|
2002-05-31 |
2013-03-12 |
Genetic Technologies Limited |
Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
|
US7290215B2
(en)
*
|
2002-06-03 |
2007-10-30 |
Microsoft Corporation |
Dynamic wizard interface system and method
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
CA2501188C
(en)
|
2002-07-15 |
2012-05-15 |
Board Of Regents, The University Of Texas System |
Combinatorial protein library screening by periplasmic expression
|
DK1537146T3
(da)
|
2002-07-15 |
2011-04-04 |
Univ Texas |
Antistoffer, der binder til anioniske phospholipider og aminophospholipider, og deres anvendelse til behandling af virusinfektioner
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
US7404951B2
(en)
|
2002-08-01 |
2008-07-29 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
PT1534736E
(pt)
|
2002-08-10 |
2010-09-07 |
Univ Yale |
Antagonistas do receptor nogo
|
AU2003278744B2
(en)
|
2002-08-28 |
2010-07-29 |
Harbor Biosciences, Inc. |
Therapeutic treatment methods
|
ATE418072T1
(de)
|
2002-09-09 |
2009-01-15 |
Arbor Vita Corp |
Verfahren zur diagnose von gebärmutterhalskrebs
|
EP2371955A1
(en)
|
2002-09-26 |
2011-10-05 |
K.U. Leuven Research & Development |
Integrase cofactor
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
MXPA05004434A
(es)
|
2002-10-24 |
2005-07-26 |
Sterix Ltd |
Inhibidores de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 y tipo 2.
|
WO2004037204A2
(en)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
EP2295980A1
(en)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
AU2002352938B8
(en)
*
|
2002-11-26 |
2009-10-08 |
The University Of Chicago |
Materials and methods for preventing and treating microbe-mediated epithelial disorders
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US8323897B2
(en)
|
2002-12-04 |
2012-12-04 |
Applied Biosystems, Llc |
Multiplex amplification of polynucleotides
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
DE60334846D1
(de)
|
2002-12-12 |
2010-12-16 |
R B T Rakuto Bio Technologies |
VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
|
ES2705683T3
(es)
|
2002-12-16 |
2019-03-26 |
Technion Res & Dev Foundation |
Medio de cultivo de células madre pluripotentes
|
AU2002953431A0
(en)
*
|
2002-12-19 |
2003-01-09 |
Murdoch University |
BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
|
JP2006512079A
(ja)
|
2003-01-02 |
2006-04-13 |
ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズ |
高血糖性患者の心疾患を予防するための抗酸化治療の有効性を予測する方法
|
US20040229245A1
(en)
*
|
2003-01-06 |
2004-11-18 |
Anton Bittner |
Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
|
EP1583713B1
(en)
*
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
US7955814B2
(en)
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
CA2512734C
(en)
|
2003-01-17 |
2012-06-19 |
Danisco A/S |
Method of producing one or more of a carbohydrate ester, a protein ester, a protein subunit ester and a hydroxy acid ester
|
MXPA05007654A
(es)
|
2003-01-17 |
2005-09-30 |
Danisco |
Metodo.
|
US20050196766A1
(en)
|
2003-12-24 |
2005-09-08 |
Soe Jorn B. |
Proteins
|
CA2514179A1
(en)
*
|
2003-01-24 |
2004-08-12 |
Duke University |
Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
|
US20050032126A1
(en)
*
|
2003-03-03 |
2005-02-10 |
Coombs James H. |
Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
|
WO2004078991A2
(en)
|
2003-03-04 |
2004-09-16 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
|
AU2004217872B2
(en)
*
|
2003-03-05 |
2010-03-25 |
Genetic Technologies Limited |
Identification of fetal DNA and fetal cell markers in maternal plasma or serum
|
AU2004217699B2
(en)
*
|
2003-03-07 |
2008-07-03 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
WO2004096157A2
(en)
|
2003-03-07 |
2004-11-11 |
New England Medical Center Hospitals, Inc. |
Treatment of igai deposition diseases
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
WO2004087042A2
(en)
|
2003-04-04 |
2004-10-14 |
Yeda Research And Development Co. Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
US8252588B2
(en)
|
2003-04-08 |
2012-08-28 |
Yeda Research And Development Co. Ltd. |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US20040209246A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Agouron Pharmaceuticals, Inc. |
Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
|
MXPA05011100A
(es)
*
|
2003-04-16 |
2006-04-18 |
Univ Yale |
Antagonistas de receptor nogo para el tratamiento de condiciones que comprenden placas amiloideas.
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
CA2978152C
(en)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP2719394B1
(en)
|
2003-06-30 |
2015-07-29 |
Tel Aviv University Future Technology Development L.P. |
Peptides for treating amyloid-associated diseases
|
EP1668111A4
(en)
|
2003-08-08 |
2008-07-02 |
Genenews Inc |
OSTEOARTHRITIS BIOMARKERS AND USES THEREOF
|
US20050064479A1
(en)
*
|
2003-08-12 |
2005-03-24 |
Affymetrix, Inc. |
Compounds and methods for post incorporation labeling of nucleic acids
|
WO2005019417A2
(en)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Bacterial strains, compositions including same and probiotic use thereof
|
EP1654349A4
(en)
|
2003-08-14 |
2008-08-20 |
Exelixis Inc |
SULFS AS BETA-CATENIN PATH MODIFICATORS AND METHOD OF USE
|
JP4711963B2
(ja)
|
2003-09-15 |
2011-06-29 |
オクラホマ メディカル リサーチ ファウンデーション |
炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
ATE509034T1
(de)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
Antikörper gegen nik, deren herstellung und verwendung
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
CA2542221A1
(en)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccine for periodontal disease
|
WO2005047324A2
(en)
|
2003-11-10 |
2005-05-26 |
Schering Corp |
ANTI-INTERLEUKIN ANTIBODY-10
|
JP5039383B2
(ja)
|
2003-11-30 |
2012-10-03 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法
|
EP2135619A1
(en)
|
2003-12-10 |
2009-12-23 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP1722834B1
(en)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring crosslinked protein backbone
|
CA2551560A1
(en)
|
2003-12-23 |
2005-07-14 |
Arbor Vita Corporation |
Antibodies for oncogenic strains of hpv and methods of their use
|
US7718408B2
(en)
*
|
2003-12-24 |
2010-05-18 |
Danisco A/S |
Method
|
WO2005066347A1
(en)
|
2003-12-24 |
2005-07-21 |
Danisco A/S |
Proteins
|
GB0716126D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20050186646A1
(en)
*
|
2004-01-26 |
2005-08-25 |
Cruz Miguel A. |
Rapid assay to detect ADAMTS-13 activity
|
WO2005071058A2
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
US20070178462A1
(en)
*
|
2004-02-18 |
2007-08-02 |
Uebele Victor N |
Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
|
US7767792B2
(en)
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
EP2208797A3
(en)
|
2004-03-01 |
2010-11-24 |
Applied Biosystems, LLC |
Methods, compositions and kits for use in polynucleotide amplification
|
JP2007526337A
(ja)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
Alk7およびミオスタチン阻害剤ならびにその使用
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
GB0405637D0
(en)
|
2004-03-12 |
2004-04-21 |
Danisco |
Protein
|
EP1730196B1
(en)
|
2004-03-12 |
2010-12-22 |
Vasgene Therapeutics, Inc. |
Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
|
BRPI0510004A
(pt)
*
|
2004-04-20 |
2007-09-18 |
Univ Chicago |
artigo de manufatura, métodos para administrar uma composição terapêutica a um epitélio de um indivìduo, para tratar uma condição mediada por micróbio de um epitélio de um indivìduo, para melhorar um sintoma de uma condição e para prevenir uma condição, e, uso de composto tipo peg pma
|
EP2400030B1
(en)
|
2004-05-18 |
2016-01-20 |
The Board of Trustees of the Leland Stanford Junior University |
Detection of protein translocation by beta-galactosidase reporter fragment complementation
|
EP2583981A3
(en)
|
2004-05-28 |
2013-07-31 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
US7812218B2
(en)
|
2004-06-14 |
2010-10-12 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
ITBO20040412A1
(it)
*
|
2004-07-01 |
2004-10-01 |
Eurodent Spa |
Lampada dentale particolarmente per ambulatori medico-dentistici
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
WO2006008508A1
(en)
|
2004-07-16 |
2006-01-26 |
Danisco A/S |
Enzymatic oil-degumming method
|
US20090233986A1
(en)
*
|
2004-07-27 |
2009-09-17 |
Mount Sinai School Of Medicine |
Methods and compositions for using sax2
|
WO2006015365A1
(en)
*
|
2004-07-30 |
2006-02-09 |
Mount Sinai School Of Medicine Of New York University |
Npc1l1 and npc1l1 inhibitors and methods of use thereof
|
US20060073168A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Stephens David S |
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
|
ES2535235T3
(es)
|
2004-08-26 |
2015-05-07 |
Engeneic Molecular Delivery Pty Ltd |
Administración de ácidos nucleicos funcionales a células de mamífero a través de minicélulas intactas obtenidas a partir de bacterias
|
FI20050753A
(fi)
|
2004-09-03 |
2006-03-04 |
Licentia Oy |
Uudet peptidit
|
ES2345993T3
(es)
|
2004-09-14 |
2010-10-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Metodo para el tratamiento con bucindolol basado en direccionamiento genetico.
|
EP1799812A4
(en)
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
|
EP1799227B1
(en)
|
2004-09-18 |
2010-11-10 |
University of Maryland, Baltimore |
Therapeutic agents targeting the nc ca-atp channel and methods of use thereof
|
CN101043891A
(zh)
|
2004-09-18 |
2007-09-26 |
巴尔的摩马里兰大学 |
靶向NCCa-ATP通道的治疗剂及其使用方法
|
EA011879B1
(ru)
|
2004-09-24 |
2009-06-30 |
Эмджин Инк. |
МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
|
WO2006035442A2
(en)
|
2004-09-29 |
2006-04-06 |
Collplant Ltd. |
Collagen producing plants and methods of generating and using same
|
EP1805319B1
(en)
*
|
2004-09-29 |
2014-09-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Recombinant human t2 rnase and uses thereof
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
US7390489B2
(en)
*
|
2004-10-08 |
2008-06-24 |
Komed Co., Ltd. |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
CA2589034C
(en)
*
|
2004-11-02 |
2016-05-31 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Compositions and methods for treating hyperproliferative disorders
|
GB0424940D0
(en)
|
2004-11-11 |
2004-12-15 |
Danisco |
Transcription factors
|
JP2008521907A
(ja)
|
2004-12-03 |
2008-06-26 |
シェーリング コーポレイション |
抗igf1r治療について患者を予め選択するためのバイオマーカー
|
US7504769B2
(en)
*
|
2004-12-16 |
2009-03-17 |
E. I. Du Pont De Nemours + Company |
Aromatic chalcogen compounds and their use
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
JP2008529325A
(ja)
*
|
2005-01-16 |
2008-07-31 |
ズランゴー リミテッド |
通信ネットワークシステムおよびそれを使用するための方法
|
WO2006075334A2
(en)
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Iconic communication
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP3028765B1
(en)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Method of sequentially transferring liquids through a lateral flow capillary device
|
EP2520669A3
(en)
|
2005-02-07 |
2013-02-27 |
GeneNews Inc. |
Mild osteoathritis biomarkers and uses thereof
|
AU2006215300C9
(en)
|
2005-02-17 |
2010-05-06 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
GB0503546D0
(en)
*
|
2005-02-21 |
2005-03-30 |
Hellenic Pasteur Inst |
Antibody
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP1863848A4
(en)
|
2005-03-31 |
2009-09-23 |
Agensys Inc |
CORRESPONDING ANTIBODIES AND MOLECULES THAT ATTACH PROTEINS 161P2F10B
|
EP1872136B9
(en)
|
2005-04-04 |
2023-02-08 |
Biogen MA Inc. |
Methods and products for evaluating an immune response to a therapeutic protein
|
WO2006109312A2
(en)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
EP2339032B1
(en)
|
2005-04-18 |
2016-12-28 |
MDNA Life Sciences Inc. |
Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
EP2224008A3
(en)
|
2005-05-12 |
2010-12-01 |
Murdoch University |
Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
|
EP2279726A3
(en)
|
2005-05-26 |
2012-06-20 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
WO2006134602A2
(en)
|
2005-06-16 |
2006-12-21 |
Ramot At Tel Aviv University Ltd. |
Isolated cells and populations comprising same for the treatment of cns diseases
|
WO2007001986A2
(en)
|
2005-06-20 |
2007-01-04 |
Yuling Luo |
Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
JP5383186B2
(ja)
*
|
2005-07-07 |
2014-01-08 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
H19をダウンレギュレートする核酸薬剤、及びそれを使用する方法
|
JP5086254B2
(ja)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
Sp1ポリペプチド、変性sp1ポリペプチドおよびそれらの使用
|
CA2615218A1
(en)
|
2005-07-18 |
2007-01-25 |
Protalix Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
US7993657B2
(en)
|
2005-07-26 |
2011-08-09 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
AU2006278260B2
(en)
*
|
2005-08-08 |
2012-03-08 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
EP2514315A3
(en)
|
2005-08-24 |
2012-11-07 |
Yeda Research and Development Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP1962719A4
(en)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
MEDIA FOR BREEDING STEM CELLS
|
ME02705B
(me)
|
2005-08-31 |
2017-10-20 |
Merck Sharp & Dohme |
Inženjerisana anti-il-23 antitela
|
US7608395B2
(en)
*
|
2005-09-15 |
2009-10-27 |
Baylor Research Institute |
Systemic lupus erythematosus diagnostic assay
|
WO2007034487A1
(en)
|
2005-09-22 |
2007-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
WO2007041340A2
(en)
*
|
2005-09-30 |
2007-04-12 |
The Trustees Of Columbia University In The City Of New York |
Microfluidic cells with parallel arrays of individual dna molecules
|
WO2007047408A2
(en)
*
|
2005-10-12 |
2007-04-26 |
Pathologica, Llc. |
Promac signature application
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
EP2319941A3
(en)
|
2005-10-21 |
2011-08-17 |
GeneNews Inc. |
Method and apparatus for correlating levels of biomarker products with disease
|
MX350551B
(es)
|
2005-10-24 |
2017-09-08 |
Evogene Ltd |
Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas que expresan los mismos y metodos para usarlos.
|
US7842823B2
(en)
*
|
2005-10-27 |
2010-11-30 |
The Regents Of The University Of California |
Fluorogenic probes for reactive oxygen species
|
WO2007051303A1
(en)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
BRPI0618338A2
(pt)
|
2005-11-07 |
2011-08-23 |
Scripps Resarch Inst |
uso de inibidor de sinalização de fator tecidual, método para identificar um agente que inibe a sinalização de tf/viia, composições farmacêuticas e kit
|
DE212006000071U1
(de)
|
2005-11-18 |
2008-07-24 |
Board of Regents, The University of Texas System, Austin |
Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2007063545A2
(en)
|
2005-11-29 |
2007-06-07 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
RU2008127252A
(ru)
|
2005-12-08 |
2010-01-20 |
Новартис АГ (CH) |
Эффекты ингибиторов fgfr3 на транскрипцию генов
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
EP2674440B1
(en)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
EP2172210A1
(en)
|
2005-12-23 |
2010-04-07 |
Partnership&Corp. Technology Transfer |
Synthetic peptides for use as inhibitors of neurotransmitter secretion
|
US7465544B2
(en)
*
|
2006-01-11 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
BRPI0707276B1
(pt)
|
2006-01-27 |
2021-08-31 |
Biogen Ma Inc |
Polipeptídeo de fusão antagonista de receptor nogo
|
DOP2007000020A
(es)
|
2006-01-31 |
2007-09-15 |
Bayer Schering Pharma Ag |
Modulación de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US7553941B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
BRPI0706967A2
(pt)
|
2006-02-06 |
2011-04-12 |
Rappaport Family Inst For Res |
método e kit para diagnosticar dmt1
|
LT1986661T
(lt)
|
2006-02-08 |
2018-12-10 |
Genzyme Corporation |
Nimano-piko a tipo ligos genų terapija
|
AU2007212278A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of South Florida |
Detection of cancer by elevated levels of Bcl-2
|
LT2676967T
(lt)
|
2006-02-28 |
2019-09-10 |
Biogen Ma Inc. |
Uždegiminių ir autoimuninių ligų gydymo būdai su natalizumabu
|
BRPI0708392A2
(pt)
|
2006-03-03 |
2011-05-24 |
Elan Pharm Inc |
métodos de tratamento de um paciente com uma doença inflamatória ou autoimune com natalizumab e de uso de natalizumab para tratar um paciente com uma doença inflamatória ou autoimune
|
EP1991852B1
(en)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Methods for identifying a cell phenotype
|
WO2007109733A2
(en)
|
2006-03-21 |
2007-09-27 |
The Johns Hopkins University |
Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
|
EP2548951B1
(en)
|
2006-03-23 |
2016-05-04 |
Pluristem Ltd. |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
EP2004858A4
(en)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
METHOD AND KITS FOR DETERMINING AN INVESTMENT TO WARFARINE RESISTANCE
|
US20070232556A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
ES2530716T3
(es)
|
2006-04-21 |
2015-03-04 |
Intervet Int Bv |
Especies de pestivirus
|
FR2900341B1
(fr)
|
2006-04-27 |
2012-09-14 |
Centre Nat Rech Scient |
Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
|
BRPI0712084A2
(pt)
*
|
2006-05-09 |
2012-01-03 |
Musc Found For Res Dev |
detecÇço de insuficiÊncia cardÍaca diastàlica por identificaÇço do perfil plasmÁtico de protease e de inibidor de protease
|
KR101442209B1
(ko)
*
|
2006-05-19 |
2014-11-18 |
테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. |
융합 단백질, 이의 용도 및 이의 제조방법
|
US20100196336A1
(en)
|
2006-05-23 |
2010-08-05 |
Dongsu Park |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
CN101505795B
(zh)
|
2006-07-03 |
2013-02-13 |
查尔斯·戴维·阿代尔 |
用于调节细胞粘附分子表达的组合物
|
JP2009544013A
(ja)
*
|
2006-07-11 |
2009-12-10 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
プロテアーゼおよびプロテアーゼ阻害因子のプロファイリングによる心筋梗塞後の心不全の予測
|
US20080026394A1
(en)
*
|
2006-07-11 |
2008-01-31 |
Antara Biosciences Inc. |
Methods of detecting one or more cancer markers
|
WO2008010934A2
(en)
|
2006-07-14 |
2008-01-24 |
Chemocentryx, Inc. |
Triazolyl phenyl benzenesulfonamides
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
US20110184747A1
(en)
*
|
2006-08-09 |
2011-07-28 |
Carmen Bozic |
Method for distribution of a drug
|
JP2008043332A
(ja)
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
RU2009110154A
(ru)
*
|
2006-08-22 |
2010-09-27 |
Джи2 ИНФЛЕММЕЙШН ПТИ ЛТД (AU) |
АНТИТЕЛА ПРОТИВ C5aR С УЛУЧШЕННЫМИ СВОЙСТВАМИ
|
EP2423332A1
(en)
|
2006-08-25 |
2012-02-29 |
Oncotherapy Science, Inc. |
Prognostic markers and therapeutic targets for lung cancer
|
US8809052B2
(en)
|
2006-08-28 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Methods of generating mature oligodendrocytes
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
JP2008111824A
(ja)
*
|
2006-09-01 |
2008-05-15 |
Nox Technologies Inc |
腫瘍特異的tNOXアイソフォーム及び方法
|
US7985542B2
(en)
*
|
2006-09-07 |
2011-07-26 |
Institut Pasteur |
Genomic morse code
|
ES2457243T3
(es)
*
|
2006-09-08 |
2014-04-25 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Diagnóstico clínico de una fibrosis hepática utilizando APOL1 de suero humano como biomarcador
|
US8055034B2
(en)
|
2006-09-13 |
2011-11-08 |
Fluidigm Corporation |
Methods and systems for image processing of microfluidic devices
|
US8050516B2
(en)
*
|
2006-09-13 |
2011-11-01 |
Fluidigm Corporation |
Methods and systems for determining a baseline during image processing
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
WO2008041183A2
(en)
|
2006-10-05 |
2008-04-10 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods of producing same
|
WO2008043566A2
(en)
|
2006-10-11 |
2008-04-17 |
Janssen Pharmaceutica N.V. |
Compositions and methods for treating and diagnosing irritable bowel syndrome
|
EP1912067A1
(en)
*
|
2006-10-12 |
2008-04-16 |
Eppendorf Array Technologies S.A. |
Method for quantification of a target compound obtained from a biological sample upon chips
|
EP2426199A3
(en)
|
2006-10-20 |
2012-08-22 |
Danisco US Inc. |
Polyol oxidases
|
JP5057402B2
(ja)
*
|
2006-10-26 |
2012-10-24 |
アボット・ラボラトリーズ |
内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
|
US7776605B2
(en)
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
JP2010507384A
(ja)
|
2006-10-27 |
2010-03-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤のプロファイリング方法
|
WO2008066655A2
(en)
|
2006-11-02 |
2008-06-05 |
Yale University |
Assessment of oocyte competence
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
CA2671264C
(en)
|
2006-11-30 |
2015-11-24 |
Research Development Foundation |
Improved immunoglobulin libraries
|
US8473216B2
(en)
*
|
2006-11-30 |
2013-06-25 |
Fluidigm Corporation |
Method and program for performing baseline correction of amplification curves in a PCR experiment
|
BRPI0720271A2
(pt)
|
2006-12-14 |
2014-01-28 |
Schering Corp |
Anticorpo anti-tslp projetado
|
CA2672756C
(en)
*
|
2006-12-20 |
2018-11-20 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8506499B2
(en)
*
|
2007-01-04 |
2013-08-13 |
Musc Foundation For Research Development |
Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
|
US8642295B2
(en)
*
|
2007-01-11 |
2014-02-04 |
Erasmus University Medical Center |
Circular chromosome conformation capture (4C)
|
CA2674949A1
(en)
|
2007-01-12 |
2008-07-24 |
J. Marc Simard |
Targeting ncca-atp channel for organ protection following ischemic episode
|
US20100086526A1
(en)
*
|
2007-01-16 |
2010-04-08 |
Abraham Hochberg |
Nucleic acid constructs and methods for specific silencing of h19
|
CA2673954C
(en)
|
2007-01-25 |
2015-09-15 |
Danisco A/S |
Production of a lipid acyltransferase from transformed bacillus licheniformis cells
|
AU2008207746B2
(en)
|
2007-01-26 |
2013-09-05 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
US20100190662A1
(en)
*
|
2007-01-26 |
2010-07-29 |
Rebecca Sutphen |
Methods and materials for detection, diagnosis and management of ovarian cancer
|
WO2008093331A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Antibody conjugates for circumventing multi-drug resistance
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
EP2125050B1
(en)
|
2007-02-01 |
2014-07-30 |
Technion Research & Development Foundation Ltd. |
Albumin fibers and fabrics and methods of generating and using same
|
EP2111412A2
(en)
|
2007-02-02 |
2009-10-28 |
Amgen, Inc |
Hepcidin and hepcidin antibodies
|
US20080220498A1
(en)
*
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
US8143046B2
(en)
*
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
KR100855299B1
(ko)
*
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
JP2008203195A
(ja)
*
|
2007-02-22 |
2008-09-04 |
Japan Science & Technology Agency |
Bshの免疫測定用キットおよびbshの測定方法
|
AR065420A1
(es)
|
2007-02-23 |
2009-06-03 |
Schering Corp |
Anticuerpos anti-il-23 p19 de ingenieria
|
EP2426145B1
(en)
|
2007-02-23 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Engineered anti-il-23p19 antibodies
|
ES2662036T3
(es)
|
2007-02-28 |
2018-04-05 |
Yeda Research And Development Company Limited |
Secuencias que se dirigen al núcleo
|
US20100105071A1
(en)
*
|
2007-02-28 |
2010-04-29 |
Children's Medical Center Corporation |
Methods for predicting the onset of menarche
|
CN101675076B
(zh)
|
2007-02-28 |
2013-09-18 |
默沙东公司 |
工程化的抗il-23r抗体
|
US20100015156A1
(en)
*
|
2007-03-06 |
2010-01-21 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
US20100216654A1
(en)
|
2007-03-12 |
2010-08-26 |
Miraculins, Inc. |
Biomarkers of prostate cancer and uses thereof
|
US8486640B2
(en)
|
2007-03-21 |
2013-07-16 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
|
EP2514766A3
(en)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
CA2933978C
(en)
|
2007-03-30 |
2018-08-21 |
Engeneic Molecular Delivery Pty. Ltd. |
Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
|
KR20100015774A
(ko)
|
2007-04-02 |
2010-02-12 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
암세포 검출 방법 및 그 질병의 진단 및 그 질병의 치료의 모니터링을 위한 상기 방법의 용도
|
CA2682299C
(en)
|
2007-04-06 |
2015-12-22 |
Becton, Dickinson And Company |
Compositions and methods for the identification of a carbapenemase gene
|
CA2683143C
(en)
|
2007-04-09 |
2018-06-12 |
Evogene Ltd. |
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
|
EP2137535B1
(en)
*
|
2007-04-13 |
2015-06-03 |
Dana-Farber Cancer Institute, Inc. |
Receptor tyrosine kinase profiling
|
EP2076289B1
(en)
|
2007-04-13 |
2014-11-12 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer resistant to erbb therapeutics
|
US8003314B2
(en)
|
2007-04-16 |
2011-08-23 |
Diagnostic Hybrids, Inc. |
Methods for direct fluorescent antibody virus detection in liquids
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
PL2144633T4
(pl)
*
|
2007-04-23 |
2015-02-27 |
Sabag Rfa Ltd |
Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
|
ES2564312T3
(es)
|
2007-05-01 |
2016-03-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Métodos y kits para detectar células fetales en la sangre materna
|
AU2008247819B2
(en)
|
2007-05-01 |
2013-02-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
WO2009009215A2
(en)
*
|
2007-05-02 |
2009-01-15 |
Emory University |
Enhancement of glycoprotein incorporation into virus-like particles
|
CN107098970B
(zh)
|
2007-05-03 |
2021-11-23 |
新加坡科技研究局 |
结合细胞内prl-1多肽或prl-3多肽的抗体
|
SI2150608T1
(en)
|
2007-05-07 |
2018-04-30 |
Protalix Ltd. |
An extensive disposable bioreactor
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
WO2009000089A1
(en)
*
|
2007-06-28 |
2008-12-31 |
University Of Saskatchewan |
Immunomodulatory compositions and methods for treating disease with modified host defense peptides
|
WO2009009662A1
(en)
*
|
2007-07-10 |
2009-01-15 |
University Of South Florida |
Method of predicting non-response to first line chemotherapy
|
US20100197767A1
(en)
|
2007-07-11 |
2010-08-05 |
Lior Nissim |
Nucleic acid construct systems capable of daignosing or treating a cell state
|
DK2175859T3
(da)
|
2007-07-12 |
2012-06-18 |
Chemocentryx Inc |
Kondenserede heteroarylpyridyl- og phenylbenzen-sulfonamider som ccr2-modulatorer til behandling af inflammation
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
ES2547305T3
(es)
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polinucleótidos, polipéptidos codificados por los mismos, y métodos de uso de los mismos para aumentar la tolerancia al estrés abiótico y/o la biomasa y/o el rendimiento en plantas que los expresan
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
JP5659014B2
(ja)
*
|
2007-08-02 |
2015-01-28 |
ジリード バイオロジクス,インク. |
線維症、腫瘍浸潤、血管新生及び転移の治療及び診断のための方法及び組成物
|
CN101821284B
(zh)
|
2007-08-03 |
2014-11-19 |
贝林格尔·英格海姆维特梅迪卡有限公司 |
猪痢疾短螺旋体的基因和蛋白质及其用途
|
US8715743B2
(en)
|
2007-08-03 |
2014-05-06 |
Musc Foundation For Research Development |
Human monoclonal antibodies and methods for producing the same
|
EP2185726B1
(en)
|
2007-08-06 |
2014-01-08 |
Orion Genomics, LLC |
Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
|
RU2488592C2
(ru)
|
2007-08-08 |
2013-07-27 |
Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем |
Пептиды направленного действия на vegfr-1/nrp-1
|
WO2009023676A1
(en)
|
2007-08-12 |
2009-02-19 |
Integrated Dna Technologies, Inc. |
Microarray system with improved sequence specificity
|
US20090136916A1
(en)
*
|
2007-08-13 |
2009-05-28 |
Trustees Of Tufts College |
Methods and microarrays for detecting enteric viruses
|
ES2406105T3
(es)
|
2007-08-15 |
2013-06-05 |
Yeda Research And Development Co. Ltd. |
Reguladores de la MMP-9 y usos de los mismos
|
WO2009034574A2
(en)
|
2007-09-12 |
2009-03-19 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
US20090068669A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Elias Georges |
Slc9a3r1 directed diagnostics for neoplastic disease
|
EP2200622B2
(en)
|
2007-09-19 |
2015-07-29 |
Pluristem Ltd. |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
EP2203749B1
(en)
|
2007-10-05 |
2012-08-29 |
Affymetrix, Inc. |
Highly multiplexed particle-based assays
|
ES2620487T3
(es)
|
2007-10-19 |
2017-06-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Composiciones que comprenden semaforinas para uso en el tratamiento del cáncer
|
WO2009069123A2
(en)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions comprising fibrous polypeptides and polysaccharides
|
CA2709517C
(en)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water use efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
CA2710713C
(en)
|
2007-12-27 |
2017-09-19 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
EP2944649A1
(en)
|
2008-01-10 |
2015-11-18 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
WO2009094551A1
(en)
|
2008-01-25 |
2009-07-30 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
CA2713667A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Cd55 isoform and uses therof in cancer detection, monitoring and therapy
|
EP2712620A1
(en)
|
2008-02-07 |
2014-04-02 |
Cornell University |
Methods for Preventing or Treating Insulin Resistance
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
WO2009103113A1
(en)
*
|
2008-02-20 |
2009-08-27 |
G2 Inflammation Pty Ltd |
HUMANIZED ANTI-C5aR ANTIBODIES
|
WO2009104174A2
(en)
|
2008-02-21 |
2009-08-27 |
Technion Research & Development Foundation Ltd . |
A method of attaching a cell-of-interest to a microtube
|
EP2363407A1
(en)
|
2008-02-28 |
2011-09-07 |
Murdoch University |
Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
|
US20090311695A1
(en)
*
|
2008-03-12 |
2009-12-17 |
Talat Nasim |
Method
|
EP2271664A4
(en)
|
2008-03-27 |
2011-11-23 |
Prionics Ag |
NEW SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITION, METHOD OF MANUFACTURE AND APPLICATION THEREOF
|
NZ602175A
(en)
*
|
2008-03-28 |
2014-03-28 |
Mitomics Inc |
Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
|
EP2107125A1
(en)
|
2008-03-31 |
2009-10-07 |
Eppendorf Array Technologies SA (EAT) |
Real-time PCR of targets on a micro-array
|
EP2280731A1
(en)
*
|
2008-04-09 |
2011-02-09 |
Technion Research and Development Foundation, Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
EP2297200A1
(en)
*
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
EP2508325A3
(en)
*
|
2008-04-10 |
2013-05-22 |
Objet Ltd. |
System and method for three dimensional model printing
|
AU2009236219B8
(en)
|
2008-04-15 |
2015-06-25 |
Arbutus Biopharma Corporation |
Silencing of CSN5 gene expression using interfering RNA
|
CA2721333C
(en)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
GB0807161D0
(en)
*
|
2008-04-18 |
2008-05-21 |
Danisco |
Process
|
EP3020410A1
(en)
|
2008-04-18 |
2016-05-18 |
Collplant Ltd. |
Methods of generating and using procollagen
|
WO2009130695A2
(en)
|
2008-04-21 |
2009-10-29 |
Danziger Innovation Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
JP2011519034A
(ja)
*
|
2008-04-23 |
2011-06-30 |
ルミネックス コーポレーション |
生物学的起原の出発材料中に見出される複数の検体のスタンダードを作成する方法
|
JP2012500620A
(ja)
|
2008-04-24 |
2012-01-12 |
ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク |
Dna分子組織化のための幾何学的パターンおよび脂質二重層、ならびにその使用
|
EP2281034B1
(en)
|
2008-04-30 |
2015-10-21 |
DuPont Nutrition Biosciences ApS |
Process using Pseudoglucanobacter saccharoketogenes alcohol dehydrogenase
|
JP2011519279A
(ja)
|
2008-05-01 |
2011-07-07 |
アムジエン・インコーポレーテツド |
抗ヘプシジン抗体及び使用の方法
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
WO2009141687A1
(en)
*
|
2008-05-22 |
2009-11-26 |
Centre National De La Recherche Scientifique (Cnrs) |
New optically pure compounds for improved therapeutic efficiency
|
BR122020021867B1
(pt)
|
2008-05-22 |
2021-05-11 |
Evogene Ltd |
método de aumento do rendimento, da taxa de crescimento, da biomassa, do vigor, da tolerância ao estresse abiótico e/ou da eficiência no uso do nitrogênio de uma planta, e, construção de ácido nucléico
|
WO2009144720A1
(en)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
EP3514229A1
(en)
|
2008-05-28 |
2019-07-24 |
Ramot at Tel-Aviv University Ltd. |
Mesenchymal stem cells for the treatment of cns diseases
|
US8791258B2
(en)
*
|
2008-06-10 |
2014-07-29 |
The Regents Of The University Of California |
Pro-fluorescent probes
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
EP2657342B1
(en)
|
2008-08-08 |
2015-11-18 |
Genisphere, LLC |
DNA dendrimers protected against nuclease degradation
|
WO2010016806A1
(en)
|
2008-08-08 |
2010-02-11 |
Agency For Science, Technology And Research (A*Star) |
Vhz for diagnosis and treatment of cancers
|
BRPI0912898B1
(pt)
|
2008-08-18 |
2022-04-12 |
Evogene Ltd |
Método para aumentar a eficiência de uso do nitrogênio e/ou tolerância à deficiência de nitrogênio de uma planta
|
RU2539786C2
(ru)
|
2008-09-02 |
2015-01-27 |
Плуристем Лтд. |
Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(en)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
COMPOSITIONS AND METHODS FOR TREATING PNEUMOCOCCAL INFECTIONS
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
EP3670524A1
(en)
|
2008-09-24 |
2020-06-24 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010036323A1
(en)
|
2008-09-25 |
2010-04-01 |
University Of Massachusetts Medical School |
Method of identifing interactions between genomic loci
|
CA2736729A1
(en)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
US8921658B2
(en)
*
|
2008-10-30 |
2014-12-30 |
Evogene Ltd. |
Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield
|
JP5805538B2
(ja)
|
2008-11-07 |
2015-11-04 |
リサーチ ディベロップメント ファウンデーション |
Cripto/GSP78複合体形成およびシグナル伝達を阻害するための組成物および方法
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010062960A2
(en)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
CA2745111A1
(en)
|
2008-12-03 |
2010-06-10 |
Research Development Foundation |
Modulation of olfml-3 mediated angiogenesis
|
WO2010064247A1
(en)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
EP3059247B1
(en)
|
2008-12-05 |
2017-09-20 |
Abraxis BioScience, LLC |
Sparc binding peptides and uses thereof
|
US8734759B2
(en)
|
2008-12-05 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
EP2373997A1
(en)
|
2008-12-09 |
2011-10-12 |
Dako Denmark A/S |
Method for evaluating pre-treatment
|
WO2010068757A1
(en)
|
2008-12-12 |
2010-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods useful for detecting and treating diseases associated with 16p chromosomal disruptions
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
AU2009334452B2
(en)
|
2008-12-29 |
2015-06-11 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076756A2
(en)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
|
WO2010076788A2
(en)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
WO2010080769A2
(en)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
WO2010086867A2
(en)
|
2009-02-02 |
2010-08-05 |
Ramot At Tel Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
US20120165340A1
(en)
|
2009-02-11 |
2012-06-28 |
Ludwing Institute For Cancer Research Ltd. |
Pten phosphorylation-driven resistance to cancer treatment and altered patient prognosis
|
IL313131A
(en)
|
2009-02-11 |
2024-07-01 |
Caris Mpi Inc |
Molecular characterization of tumors
|
ES2544265T3
(es)
|
2009-02-11 |
2015-08-28 |
Orion Genomics, Llc |
Combinaciones de polimorfismos para determinar la expresión específica de alelo de IGF2
|
WO2010096658A1
(en)
|
2009-02-19 |
2010-08-26 |
The Cleveland Clinic Foundation |
Corin as a marker for heart failure
|
EP2401362B1
(en)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
AR075773A1
(es)
|
2009-03-02 |
2011-04-27 |
Evogene Ltd |
Polipetidos y polinucleotidos aislados y metodos para su uso en el aumento del rendimiento de plantas y las caracteristicas agricolas
|
WO2010103515A2
(en)
|
2009-03-09 |
2010-09-16 |
Ramot At Tel Aviv University Ltd. |
Compositions and methods for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
US20100240065A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Prolyl Hydroxylase Compositions and Methods of Use Thereof
|
US8481698B2
(en)
*
|
2009-03-19 |
2013-07-09 |
The President And Fellows Of Harvard College |
Parallel proximity ligation event analysis
|
AU2010241947B2
(en)
|
2009-03-27 |
2014-01-16 |
Gojo Industries, Inc. |
Compositions and methods for screening and using compounds antagonizing spore-surface interactions
|
EP3272871B1
(en)
|
2009-03-27 |
2020-01-15 |
MDNA Life Sciences Inc. |
Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
|
EP2414542B1
(en)
|
2009-03-30 |
2017-08-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Methods of predicting clinical course and treating multiple sclerosis
|
EP2344179A1
(en)
|
2009-04-01 |
2011-07-20 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
A method of regulating proliferation and differentiation of keratinocyes
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
AU2010239131A1
(en)
|
2009-04-21 |
2011-11-17 |
Genetic Technologies Limited |
Methods for obtaining fetal genetic material
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
LT2990421T
(lt)
|
2009-04-30 |
2018-04-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anti-ceacam1 antikūnai ir jų panaudojimo būdai
|
EP2425253B1
(en)
|
2009-05-01 |
2017-03-22 |
Dako Denmark A/S |
New antibody cocktail
|
CA2761692A1
(en)
*
|
2009-05-14 |
2010-11-25 |
Raymond A. Dwek |
Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
|
US9182403B2
(en)
|
2009-05-19 |
2015-11-10 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
AU2010250810B2
(en)
|
2009-05-19 |
2014-03-20 |
Dupont Nutrition Biosciences Aps |
Use
|
WO2011019423A2
(en)
|
2009-05-20 |
2011-02-17 |
Schering Corporation |
Modulation of pilr receptors to treat microbial infections
|
EP2435072A2
(en)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
CN102439451B
(zh)
|
2009-06-02 |
2014-12-03 |
德克萨斯大学系统董事会 |
患神经退行性疾病的对象中抗体所识别的小分子的鉴定
|
EP3238534B1
(en)
|
2009-06-10 |
2019-11-13 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
CA2765779A1
(en)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
CA2766009A1
(en)
|
2009-06-25 |
2010-12-29 |
Danisco A/S |
Variant lipolytic enzymes with improved expression, functionality and/or activity
|
EP2449107B1
(en)
|
2009-06-29 |
2015-04-08 |
The University Of Western Australia |
Terpene synthases from santalum
|
JP5766188B2
(ja)
|
2009-07-01 |
2015-08-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
固形腫瘍に治療剤を送達するための脂質製剤
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
MY160472A
(en)
|
2009-07-17 |
2017-03-15 |
Bioatla Llc |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
WO2011010309A1
(en)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
EP2467470A2
(en)
|
2009-08-17 |
2012-06-27 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
EP2467146A1
(en)
|
2009-08-21 |
2012-06-27 |
Beeologics Inc. |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
BR112012008054A2
(pt)
|
2009-08-21 |
2017-05-23 |
Gilead Biologics Inc |
domínios catalíticos de lisil oxidase e loxl2
|
WO2011024172A2
(en)
|
2009-08-27 |
2011-03-03 |
Technion Research & Development Foundation Ltd. |
Liposomal compositions and uses of same
|
RU2595409C2
(ru)
|
2009-09-03 |
2016-08-27 |
Мерк Шарп И Доум Корп., |
Анти-gitr-антитела
|
EP2475784A1
(en)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011030329A1
(en)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
EP2477652B1
(en)
|
2009-09-16 |
2015-04-15 |
Vaxart, Inc. |
Immunization strategy to prevent h1n1 infection
|
CA2773935C
(en)
|
2009-09-17 |
2018-06-19 |
Ramot At Tel Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
EP2480668A2
(en)
|
2009-09-23 |
2012-08-01 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing genes expressed in cancer
|
US20130023433A1
(en)
|
2009-09-28 |
2013-01-24 |
Yuling Luo |
Methods of detecting nucleic acid sequences with high specificity
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
EP2483316A1
(en)
|
2009-10-02 |
2012-08-08 |
Ludwig Institute for Cancer Research Ltd. |
Anti-fibroblast activation protein antibodies and methods and uses thereof
|
WO2011040973A2
(en)
|
2009-10-02 |
2011-04-07 |
Ludwig Institute For Cancer Research Ltd. |
Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
|
WO2011044186A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
ES2666372T3
(es)
|
2009-10-11 |
2018-05-04 |
Biogen Ma Inc. |
Ensayos relacionados con anti-VLA-4
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
EP3272869B1
(en)
|
2009-10-14 |
2020-06-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Compositions for controlling varroa mites in bees
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
WO2011056688A2
(en)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Molecular profiling for personalized medicine
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
EP2498806B1
(en)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
EP4166652A1
(en)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
EP2501800A4
(en)
|
2009-11-17 |
2013-05-22 |
Musc Found For Res Dev |
HUMAN MONOCLONAL ANTIBODIES FOR HUMAN NUCLEOLIN
|
WO2011061736A1
(en)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alkaline alpha galactosidase for the treatment of fabry disease
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
GB0920089D0
(en)
|
2009-11-17 |
2009-12-30 |
Danisco |
Method
|
US9910040B2
(en)
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
US9733242B2
(en)
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
WO2011064669A2
(en)
|
2009-11-30 |
2011-06-03 |
Pluristem Ltd. |
Adherent cells from placenta and use of same in disease treatment
|
US8835120B2
(en)
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US8652788B2
(en)
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US20110136141A1
(en)
*
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
US8183002B2
(en)
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
US8691227B2
(en)
|
2009-12-17 |
2014-04-08 |
Merck Sharp & Dohme Corp. |
Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
US9493785B2
(en)
|
2009-12-28 |
2016-11-15 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
AU2010337829B2
(en)
|
2009-12-29 |
2015-03-19 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
CA2786374C
(en)
|
2010-01-05 |
2019-01-22 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
WO2011084882A2
(en)
|
2010-01-05 |
2011-07-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
PL2524060T3
(pl)
|
2010-01-11 |
2018-05-30 |
Biogen Ma Inc. |
Test wykrywający przeciwciała przeciwko wirusowi jc
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
SG182490A1
(en)
|
2010-01-12 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
EA201270701A1
(ru)
|
2010-01-27 |
2013-01-30 |
Йеда Рисеч Энд Девелопмент Ко. Лтд. |
Ингибирующие металлопротеины антитела
|
US20130171621A1
(en)
|
2010-01-29 |
2013-07-04 |
Advanced Cell Diagnostics Inc. |
Methods of in situ detection of nucleic acids
|
US8574832B2
(en)
|
2010-02-03 |
2013-11-05 |
Massachusetts Institute Of Technology |
Methods for preparing sequencing libraries
|
RU2549684C2
(ru)
|
2010-02-04 |
2015-04-27 |
Джилид Байолоджикс, Инк. |
Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
|
WO2011097627A1
(en)
|
2010-02-08 |
2011-08-11 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to 161p2f10b proteins
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
WO2011104708A2
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
WO2011111034A1
(en)
|
2010-03-08 |
2011-09-15 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
ES2809679T3
(es)
|
2010-03-08 |
2021-03-05 |
Monsanto Technology Llc |
Moléculas polinucleotídicas para la regulación génica en plantas
|
US20120329089A1
(en)
|
2010-03-11 |
2012-12-27 |
Jacob Edrei |
Methods of generating hydrogen
|
WO2011114251A1
(en)
|
2010-03-18 |
2011-09-22 |
Danisco A/S |
Foodstuff
|
EP2556085A2
(en)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
US9125931B2
(en)
|
2010-04-06 |
2015-09-08 |
Massachusetts Institute Of Technology |
Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
|
CN103168118A
(zh)
|
2010-04-06 |
2013-06-19 |
麻省理工学院 |
用减少数量的转录物测量进行的基因表达概况分析
|
WO2011128895A2
(en)
|
2010-04-12 |
2011-10-20 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
JP5786020B2
(ja)
|
2010-04-16 |
2015-09-30 |
アボットジャパン株式会社 |
関節リウマチを診断する方法および試薬
|
JP5858984B2
(ja)
|
2010-04-18 |
2016-02-10 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ErbB/ErbBリガンドに関連する疾患を治療するための分子及びその分子を使用する方法
|
BR122021002337B1
(pt)
|
2010-04-28 |
2022-03-22 |
Evogene Ltd |
Método de aumento de produção, biomassa, taxa de crescimento, vigor, teor de óleo, produção de fibra qualidade de fibra, tolerância ao estresse abiótico e/ou eficiência de uso de nitrogênio de uma planta, e construto de ácido nucleico isolado
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
WO2011138785A2
(en)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of ccl1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
MX2012012986A
(es)
|
2010-05-07 |
2013-03-05 |
Abbvie Inc |
Metodos para predecir la sensibilidad al tratamiento con un inhibidor de cinasa de tirosina dirigido.
|
WO2011141914A1
(en)
|
2010-05-13 |
2011-11-17 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
US20110287458A1
(en)
|
2010-05-18 |
2011-11-24 |
The Texas A&M University System |
Method and composition for the diagnosis and monitoring of inflammatory diseases
|
EP2576622A4
(en)
|
2010-06-01 |
2013-11-27 |
Univ Monash |
ANTIBODIES AGAINST RECEPTOR TYROSINE KINASE C-MET
|
US9624285B2
(en)
|
2010-06-03 |
2017-04-18 |
Ramot a Tel-Aviv University Ltd. |
Methods of treating diabetes and compositions capable of same
|
AU2011263306A1
(en)
|
2010-06-07 |
2013-01-10 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
WO2011158243A2
(en)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
US20130316338A1
(en)
|
2010-06-29 |
2013-11-28 |
The United States Government As Represented By The Department Of Veterans Affairs |
CCR6 As A Biomarker of Alzheimer's Disease
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
EP2407242A1
(en)
|
2010-07-13 |
2012-01-18 |
Dublin City University |
Direct clone analysis and selection technology
|
BR112013000985A2
(pt)
|
2010-07-15 |
2017-09-05 |
Technion Res & Dev Foundation |
Entidades isoladas de alta afinidade com especificidade semelhante à do receptor de célula t em relação a complexos nativos de mhc classe ii e peptídeos autoantigênicos de descarboxilase do ácido glutâmico (gad)
|
EP2593480A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
EP2593554A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research And Development Foundation Ltd. |
Nucleic acid construct for increasing abiotic stress tolerance in plants
|
WO2012009627A2
(en)
|
2010-07-16 |
2012-01-19 |
Vanderbilt University |
Low resource processor using surface tension valves for extracting, concentrating and detecting molecular species
|
SG187033A1
(en)
|
2010-07-16 |
2013-02-28 |
Bioatla Llc |
Novel methods of protein evolution
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
CN103026230B
(zh)
|
2010-07-23 |
2015-01-14 |
卢米耐克斯公司 |
共偶联以控制免疫测定中试剂的反应性
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US20130130387A1
(en)
|
2010-07-27 |
2013-05-23 |
Technion Research & Development Foundation Limited |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
US9394523B2
(en)
|
2010-08-22 |
2016-07-19 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
BR122019017037B1
(pt)
|
2010-08-30 |
2022-05-31 |
Evogene Ltd |
Método de aumento de eficiência do uso de nitrogênio, rendimento, biomassa, taxa de crescimento, vigor e/ou tolerância ao estresse à deficiência de nitrogênio de uma planta
|
SG188411A1
(en)
|
2010-09-07 |
2013-04-30 |
Technion Res & Dev Foundation |
Novel methods and culture media for culturing pluripotent stem cells
|
EP2613799A1
(en)
|
2010-09-07 |
2013-07-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
PT2613801T
(pt)
|
2010-09-08 |
2016-09-12 |
Yeda Res & Dev |
Utilização de células t de memória central anti-terceiros no tratamento anti-leucemia/linfoma
|
MX2013002667A
(es)
|
2010-09-08 |
2013-08-01 |
Yeda Res & Dev |
Una combinacion de farmacos inmunosupresores para un injerto estable y a largo plazo.
|
WO2012035539A1
(en)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
EP2619321B1
(en)
|
2010-09-20 |
2018-08-01 |
Advanced Cell Diagnostics, Inc. |
Biomarkers for differentiating melanoma from benign nevus in the skin
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
IL290591B2
(en)
|
2010-09-29 |
2024-08-01 |
Seagen Inc |
Antibody drug preparations (ADC) that bind to 191P4D12 proteins
|
BR112013008026A2
(pt)
|
2010-10-04 |
2016-06-21 |
Centre Nat Rech Scient |
composições que compreendem ligantes sintéticos multivalentes de nucleolina de superfície e glicosaminaglicanos
|
EP2441520A1
(en)
|
2010-10-12 |
2012-04-18 |
Eppendorf AG |
Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
|
EP2627766B1
(en)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
EP3034625B1
(en)
|
2010-10-21 |
2017-10-04 |
Advanced Cell Diagnostics, Inc. |
An ultra sensitive method for in situ detection of nucleic acids
|
WO2012056452A2
(en)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
US20130227724A1
(en)
|
2010-11-03 |
2013-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
WO2012066549A1
(en)
|
2010-11-15 |
2012-05-24 |
Ramot At Tel-Aviv University Ltd. |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
EP2640404B1
(en)
|
2010-11-17 |
2017-02-22 |
Ben Gurion University of The Negev Research and Development Authority |
T-cell therapy to neurodegenerative diseases
|
WO2012073238A1
(en)
|
2010-12-02 |
2012-06-07 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
EP2463382A1
(en)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Method for identifying E. Coli M-17
|
EP2652125B1
(en)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
US9551006B2
(en)
|
2010-12-22 |
2017-01-24 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
EP2658562B1
(en)
|
2010-12-28 |
2017-07-26 |
Kamedis Ltd. |
Plant extracts for the treatment and prevention of infections
|
WO2012092376A2
(en)
|
2010-12-31 |
2012-07-05 |
Short Jay M |
Comprehensive monoclonal antibody generation
|
EP3567121B1
(en)
|
2011-01-17 |
2023-08-30 |
Life Technologies Corporation |
Workflow for detection of ligands using nucleic acids
|
PT3272861T
(pt)
|
2011-01-20 |
2020-03-26 |
Protalix Ltd |
Construção de ácido nucleico para expressão de alfα-galactosidase em plantas e células de plantas
|
WO2012103414A2
(en)
|
2011-01-28 |
2012-08-02 |
Advanced Cell Diagnostics, Inc. |
Rnascope® hpv assay for determining hpv status in head and neck cancers and cervical lesions
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US8658128B2
(en)
|
2011-02-03 |
2014-02-25 |
Pop Test Cortisol Llc |
System and method for diagnosis and treatment
|
CA2826467C
(en)
|
2011-02-07 |
2019-11-12 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
WO2012116073A2
(en)
|
2011-02-23 |
2012-08-30 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic dendron-coils, micelles thereof and uses
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
WO2012117406A2
(en)
|
2011-03-02 |
2012-09-07 |
Futuragene Israel Ltd. |
Bacterial resistant transgenic plants
|
EP2680864B1
(en)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
CA2829110C
(en)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
AU2012226530B2
(en)
|
2011-03-08 |
2016-12-01 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
EP2684048B1
(en)
|
2011-03-11 |
2018-10-03 |
Board of Regents of the University of Nebraska |
Biomarker for coronary artery disease
|
BR112013023653A2
(pt)
|
2011-03-17 |
2016-12-13 |
Univ Ramot |
anticorpo biespecífico, método de preparação do anticorpo, e composição farmacêutica
|
CN103533934B
(zh)
|
2011-03-17 |
2016-03-30 |
特尔汗什莫尔医学基础设施研究和服务公司 |
用于治疗自身免疫性疾病的喹诺酮类似物
|
JP2014511677A
(ja)
|
2011-03-22 |
2014-05-19 |
コーネル・ユニバーシティー |
鑑別困難な良性甲状腺病変と悪性甲状腺病変との識別法
|
KR101903339B1
(ko)
|
2011-03-22 |
2018-10-01 |
플루리스템 리미티드 |
방사선 또는 화학적 손상을 치료하는 방법
|
JP5960793B2
(ja)
|
2011-03-24 |
2016-08-02 |
ニューリム ファーマシューティカルズ(1991)リミテッド |
神経保護ペプチド
|
JP2014510533A
(ja)
|
2011-03-28 |
2014-05-01 |
ノバルティス アーゲー |
サイクリン依存性キナーゼ阻害剤に関連するマーカー
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
KR102489185B1
(ko)
|
2011-04-01 |
2023-01-17 |
이뮤노젠 아이엔씨 |
Folr1 암 치료의 효능을 증가시키기 위한 방법
|
EP2694095B1
(en)
|
2011-04-05 |
2018-03-07 |
Longevity Biotech, Inc. |
Compositions comprising glucagon analogs and methods of making and using the same
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
KR102010600B1
(ko)
|
2011-04-06 |
2019-08-13 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
대사 활성 프로필을 모니터링 및 분석하는 방법 및 그의 진단 및 치료학적 용도
|
US20140031272A1
(en)
|
2011-04-08 |
2014-01-30 |
Danisco Us Inc. |
Compositions
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
CA2832812C
(en)
|
2011-04-15 |
2017-12-05 |
Pluristem Ltd. |
Methods and systems for harvesting cells
|
US9034322B2
(en)
|
2011-04-21 |
2015-05-19 |
The Rockefeller University |
Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
|
CA3137817A1
(en)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
EP2704793B1
(en)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
US9506051B2
(en)
|
2011-05-20 |
2016-11-29 |
Oligomerix, Inc. |
Tau protease compositions and methods of use
|
CN107102135A
(zh)
|
2011-05-20 |
2017-08-29 |
阿波特日本有限公司 |
用于减少非特异性结合的免疫检验方法和试剂
|
WO2012160563A2
(en)
|
2011-05-23 |
2012-11-29 |
Yeda Research And Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
EP2714719B1
(en)
|
2011-05-31 |
2018-12-12 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion and detachment of cell aggregates
|
KR102292563B1
(ko)
|
2011-05-31 |
2021-08-24 |
바이오젠 엠에이 인코포레이티드 |
Pml의 위험을 판단하는 방법
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
PT3424953T
(pt)
|
2011-06-06 |
2020-11-03 |
Novo Nordisk As |
Anticorpos terapêuticos
|
EP2720720B1
(en)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Combination therapy to prevent dcis formation and progression to breast cancer
|
WO2012176203A1
(en)
|
2011-06-23 |
2012-12-27 |
Kaiima Bio Agritech Ltd. |
Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
|
US9835621B2
(en)
|
2011-07-14 |
2017-12-05 |
University Of Kentucky Research Foundation |
Process for detection of alzheimer's disease from a serum sample
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
JP2014523914A
(ja)
|
2011-07-18 |
2014-09-18 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作された微生物標的化分子およびその使用
|
RU2014106125A
(ru)
|
2011-07-20 |
2015-08-27 |
Каиима Био Агритех Лтд. |
Растения кукурузы с частично или полностью умноженным геномом и их применения
|
EP2550982A1
(en)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Devices for surgical applications
|
CA2844012C
(en)
|
2011-08-04 |
2021-03-16 |
Yeda Research And Development Co. Ltd. |
Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
AU2012294814A1
(en)
|
2011-08-05 |
2014-02-27 |
Research Development Foundation |
Improved methods and compositions for modulation of Olfml3 mediated angiogenesis
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
AU2012296138A1
(en)
|
2011-08-14 |
2014-03-06 |
Kaiima Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
EP2744517B1
(en)
|
2011-08-15 |
2019-03-13 |
The University of Chicago |
Compositions and methods related to antibodies to staphylococcal protein a
|
EP3348575A1
(en)
|
2011-08-16 |
2018-07-18 |
Emory University |
Jaml specific binding agents, antibodies, and uses related thereto
|
WO2013035070A1
(en)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
CN103890195A
(zh)
|
2011-09-08 |
2014-06-25 |
耶达研究及发展有限公司 |
用于肺癌的新型风险生物标志物
|
EP2755466A4
(en)
|
2011-09-13 |
2015-04-15 |
Monsanto Technology Llc |
METHODS AND COMPOSITIONS FOR CONTROLLING WEEDS
|
BR112014005979A8
(pt)
|
2011-09-13 |
2017-09-12 |
Monsanto Technology Llc |
Métodos e composições quimicas agricolas para controle de planta, método de redução de expressão de um gene ppg oxidase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene ppg oxidase e mistura herbicida
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3296402B1
(en)
|
2011-09-13 |
2020-04-15 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US9840715B1
(en)
|
2011-09-13 |
2017-12-12 |
Monsanto Technology Llc |
Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
|
CA2848680C
(en)
|
2011-09-13 |
2020-05-19 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US9920326B1
(en)
|
2011-09-14 |
2018-03-20 |
Monsanto Technology Llc |
Methods and compositions for increasing invertase activity in plants
|
US9249467B2
(en)
|
2011-09-16 |
2016-02-02 |
Steven Goodison |
Bladder cancer detection composition, kit and associated methods
|
CN108424464A
(zh)
|
2011-10-05 |
2018-08-21 |
洛克菲勒大学 |
二聚噬菌体溶素
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
BR112014009536A2
(pt)
|
2011-10-21 |
2017-04-18 |
Augurex Life Sciences Corp |
antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
|
WO2013061328A2
(en)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Method of treating cancer
|
WO2013064163A1
(en)
|
2011-11-01 |
2013-05-10 |
Academisch Medisch Centrum |
Methylation markers for colorectal cancer
|
EP2773758B1
(en)
|
2011-11-03 |
2017-06-07 |
Quark Pharmaceuticals, Inc. |
Compositions for use in neuroprotection
|
EP2776565A1
(en)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
WO2013076730A1
(en)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis and compositions capable of same
|
SG11201402902VA
(en)
|
2011-12-08 |
2014-07-30 |
Yeda Res & Dev |
Mammalian fetal pulmonary cells and therapeutic use of same
|
EP3270143B1
(en)
|
2011-12-12 |
2021-04-21 |
Senturion Water Monitoring, LLC |
Method for determining error in a chemical indicator reading and hardware storage device comprising instructions for performing the method
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
CN105833925B
(zh)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
RU2648354C2
(ru)
|
2011-12-22 |
2018-03-23 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Комбинированная терапия для стабильного и долговременного приживления трансплантата с использованием конкретных протоколов для т/в-клеточной деплеции
|
CN104270939A
(zh)
|
2011-12-28 |
2015-01-07 |
凯伊玛生物农业科技有限公司 |
具有部分加倍或完全加倍的基因组的栽培高粱植物及其应用
|
KR20140108718A
(ko)
|
2011-12-29 |
2014-09-12 |
베일러 리서치 인스티튜트 |
가와사키 질환용 바이오마커
|
CN104080480A
(zh)
|
2012-01-01 |
2014-10-01 |
奇比艾企业有限公司 |
用于选择性递送治疗剂和诊断剂的endo180靶向微粒
|
EP3418397B1
(en)
|
2012-01-24 |
2020-10-07 |
CD Diagnostics, Inc. |
System for detecting infection in synovial fluid
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
US20150010527A1
(en)
|
2012-02-01 |
2015-01-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
BR112014020119A2
(pt)
|
2012-02-13 |
2020-10-27 |
Gamida-Cell Ltd |
cultura de células-tronco mesenquimais
|
EP2822576B1
(en)
|
2012-02-14 |
2018-01-10 |
OPKO Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
KR20140130495A
(ko)
|
2012-02-19 |
2014-11-10 |
프로탈릭스 리미티드 |
고셰병 치료용 경구형 단위 투약 형태 및 이의 용도
|
EP3401393B1
(en)
|
2012-02-22 |
2020-02-19 |
Exostem Biotec Ltd |
Micrornas for the generation of astrocytes
|
EP2844745A2
(en)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
KR102075810B1
(ko)
|
2012-02-24 |
2020-02-10 |
아뷰터스 바이오파마 코포레이션 |
트리알킬 양이온성 지질 및 그의 사용 방법
|
SG11201405241VA
(en)
|
2012-02-29 |
2014-09-26 |
Chemocentryx Inc |
Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists
|
EP2833714A1
(en)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
ES2691931T3
(es)
|
2012-03-07 |
2018-11-29 |
Yeda Research And Development Co. Ltd. |
Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
|
RS58910B1
(sr)
|
2012-03-20 |
2019-08-30 |
Biogen Ma Inc |
Antitela koja neutrališu virus jcv
|
EP2828280B1
(en)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Plif multimeric peptides and uses thereof
|
CA2868883C
(en)
|
2012-03-30 |
2022-10-04 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
US20140178869A1
(en)
|
2012-04-05 |
2014-06-26 |
Advanced Cell Diagnostics, Inc. |
Detection of immunoglobulin light chain restriction by rna in situ hybridization
|
AU2013250767A1
(en)
|
2012-04-18 |
2014-10-09 |
Quiet Therapeutics Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
EP2838552A4
(en)
|
2012-04-19 |
2016-05-18 |
Opko Biolog Ltd |
OXYNTOMODULIN VARIANTS WITH EXTENDED ACTION AND PROCESSES FOR PRODUCING SAME
|
US20130280696A1
(en)
|
2012-04-23 |
2013-10-24 |
Elliott Millenson |
Devices and methods for detecting analyte in bodily fluid
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
CN104703622B
(zh)
|
2012-04-26 |
2017-05-24 |
芝加哥大学 |
与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
CN104583239B
(zh)
|
2012-05-10 |
2018-09-18 |
生物蛋白有限公司 |
多特异单克隆抗体
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
JP5868549B2
(ja)
|
2012-05-24 |
2016-02-24 |
マウントゲイト グループ リミテッド |
狂犬病感染の予防および治療に関する組成物および方法
|
US10240162B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
CA2872030A1
(en)
|
2012-05-31 |
2013-12-05 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind pd-l1
|
CA2874146C
(en)
|
2012-06-01 |
2023-03-21 |
Icahn School Of Medicine At Mount Sinai |
Ceramide levels in the treatment and prevention of infections
|
US9731048B2
(en)
|
2012-06-03 |
2017-08-15 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
PE20150181A1
(es)
|
2012-06-04 |
2015-02-28 |
Opko Biolog Ltd |
Variantes de oxm pegilada
|
JP6429771B2
(ja)
|
2012-06-21 |
2018-11-28 |
ソレント・セラピューティクス・インコーポレイテッドSorrento Therapeutics, Inc. |
c−Metに結合する抗原結合タンパク質
|
CN104603291B
(zh)
|
2012-06-22 |
2018-04-06 |
Htg分子诊断有限公司 |
黑素细胞病变中的分子恶性肿瘤
|
CA2877814A1
(en)
|
2012-06-22 |
2013-12-27 |
Dingqiu HUANG |
Antigen binding proteins that bind ccr2
|
EP2870110A1
(en)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
EP3309263B1
(en)
|
2012-07-09 |
2019-12-25 |
Novartis AG |
Biomarkers associated with cdk inhibitors
|
AU2013290146B2
(en)
|
2012-07-11 |
2018-01-18 |
Imstem Biotechnology, Inc. |
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
|
US20150173883A1
(en)
|
2012-07-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Modification of surfaces for simultaneous repellency and targeted binding of desired moieties
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
KR102250696B1
(ko)
|
2012-07-27 |
2021-05-12 |
더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 |
T 세포 수용체 조작
|
EP2880155B1
(en)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
CN104520714A
(zh)
|
2012-07-31 |
2015-04-15 |
诺华股份有限公司 |
与对人双微体2(mdm2)抑制剂的敏感性相关的标志物
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
ES2813407T3
(es)
|
2012-08-06 |
2021-03-23 |
Brainstorm Cell Therapeutics Ltd |
Métodos para generar células madre mesenquimales que secretan factores neurotróficos
|
US8968742B2
(en)
|
2012-08-23 |
2015-03-03 |
Agensys, Inc. |
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
|
WO2014033723A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
US10543278B2
(en)
|
2012-09-12 |
2020-01-28 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
EP3677310A1
(en)
|
2012-10-08 |
2020-07-08 |
St. Jude Children's Research Hospital |
Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axis
|
EP2906954B1
(en)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
US9650436B2
(en)
|
2012-10-12 |
2017-05-16 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
EP2908620A4
(en)
|
2012-10-18 |
2016-07-27 |
Monsanto Technology Llc |
METHODS AND COMPOSITIONS FOR CONTROLLING PHYTOPARASITES
|
WO2014063097A1
(en)
|
2012-10-19 |
2014-04-24 |
Danisco Us Inc. |
Stabilization of biomimetic membranes
|
US9395369B2
(en)
|
2012-10-19 |
2016-07-19 |
Regents Of The University Of Minnesota |
Guinea pig cytomegalovirus (CIDMTR strain)
|
US20150354006A1
(en)
|
2012-10-19 |
2015-12-10 |
Novartis Ag |
Markers for acute lymphoblastic leukemia
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
CA2888345C
(en)
|
2012-10-24 |
2020-04-21 |
Research Development Foundation |
Jam-c antibodies and methods for treatment of cancer
|
WO2014064682A1
(en)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
EP2912181B1
(en)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
WO2014080401A2
(en)
|
2012-11-20 |
2014-05-30 |
Prolor Biotech Inc |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
BR112015002626A2
(pt)
|
2012-11-29 |
2017-09-26 |
Yeda Res & Dev |
métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
CN105358695B
(zh)
|
2013-01-01 |
2019-07-12 |
A.B.种子有限公司 |
将dsRNA引入植物种子以调节基因表达的方法
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
US10047399B2
(en)
|
2013-01-07 |
2018-08-14 |
The Cleveland Clinic Foundation |
ABCA1 downregulation in prostate cancer
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
EP3431985A1
(en)
|
2013-01-17 |
2019-01-23 |
Novellusdx Ltd. |
Methods and systems for identifying patient specific driver mutations
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
US10000767B2
(en)
|
2013-01-28 |
2018-06-19 |
Monsanto Technology Llc |
Methods and compositions for plant pest control
|
AU2014212230B2
(en)
|
2013-02-01 |
2019-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)
|
EP3885446A1
(en)
|
2013-02-01 |
2021-09-29 |
The Regents of The University of California |
Methods for genome assembly and haplotype phasing
|
US9411930B2
(en)
|
2013-02-01 |
2016-08-09 |
The Regents Of The University Of California |
Methods for genome assembly and haplotype phasing
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
WO2014130846A1
(en)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Transdermal drug delivery using amphiphilic dendron-coil micelles
|
JP6454650B2
(ja)
|
2013-03-06 |
2019-01-23 |
プロタリクス リミテッド |
TNFαポリペプチド阻害剤を発現する植物細胞及び薬学的に許容される担体を含む医薬組成物
|
AU2014224174B2
(en)
|
2013-03-06 |
2018-08-30 |
Hadasit Medical Research Services And Development Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
TWI582239B
(zh)
|
2013-03-11 |
2017-05-11 |
諾華公司 |
與wnt抑制劑相關之標記
|
US10609930B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10612019B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2014159242A1
(en)
|
2013-03-14 |
2014-10-02 |
Novartis Ag |
Notch 3 mutants and uses thereof
|
CN105246916A
(zh)
|
2013-03-14 |
2016-01-13 |
诺华股份有限公司 |
针对notch 3的抗体
|
CN105452292A
(zh)
|
2013-03-14 |
2016-03-30 |
帕卡什·吉尔 |
使用结合细胞表面grp78的抗体进行癌症治疗
|
US9273349B2
(en)
|
2013-03-14 |
2016-03-01 |
Affymetrix, Inc. |
Detection of nucleic acids
|
US20140283211A1
(en)
|
2013-03-14 |
2014-09-18 |
Monsanto Technology Llc |
Methods and Compositions for Plant Pest Control
|
WO2014145718A2
(en)
|
2013-03-15 |
2014-09-18 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
US9944992B2
(en)
|
2013-03-15 |
2018-04-17 |
The University Of Chicago |
Methods and compositions related to T-cell activity
|
US20140273031A1
(en)
|
2013-03-15 |
2014-09-18 |
The Cleveland Clinic Foundation |
In-vitro method for monoclonal antibody production
|
EP4174082A1
(en)
|
2013-03-15 |
2023-05-03 |
GLAdiator Biosciences, Inc. |
Gla domains as targeting agents
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2907680A1
(en)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprising collagen and prp for tissue regeneration
|
CN105163749B
(zh)
|
2013-03-24 |
2018-03-27 |
拜欧肯治疗有限公司 |
治疗骨髓性白血病的方法
|
AU2014241162A1
(en)
|
2013-03-27 |
2015-10-22 |
Cedars-Sinai Medical Center |
Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
WO2014174511A1
(en)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
EP2989199B1
(en)
|
2013-04-23 |
2020-08-12 |
Yeda Research and Development Co., Ltd. |
Isolated naive pluripotent stem cells and methods of generating same
|
WO2014174520A1
(en)
|
2013-04-25 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
US20160091485A1
(en)
|
2013-04-25 |
2016-03-31 |
The Broad Institute, Inc. |
Markers for ezh2 inhibitors
|
EP3848044A1
(en)
|
2013-05-21 |
2021-07-14 |
President and Fellows of Harvard College |
Engineered heme-binding compositions and uses thereof
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
KR102280377B1
(ko)
|
2013-05-27 |
2021-07-23 |
라쿠토 바이오 테크놀로지스 리미티드 |
효소 시스템-함유 화장료 조성물
|
EP3004334A4
(en)
|
2013-05-28 |
2016-12-21 |
Biogen Ma Inc |
METHODS OF EVALUATION RISK OF DEVELOPMENT OF PML
|
EP3008201B1
(en)
|
2013-06-12 |
2019-08-07 |
The General Hospital Corporation |
Methods for multiplexed detection of target molecules and uses thereof
|
DK3010519T3
(en)
|
2013-06-18 |
2021-05-17 |
Dnatrix Inc |
Oncolytic adenovirus for use in a treatment of brain cancer
|
WO2014205230A1
(en)
|
2013-06-19 |
2014-12-24 |
Step Ahead Innovations Inc. |
Aquatic environment water parameter testing systems and methods
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
AU2014302082B2
(en)
|
2013-06-28 |
2019-08-08 |
Baylor Research Institute |
Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
|
WO2015010108A1
(en)
|
2013-07-19 |
2015-01-22 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
BR112016000555B1
(pt)
|
2013-07-19 |
2022-12-27 |
Monsanto Technology Llc |
Método para controlar uma infestação da espécie de leptinotarsa em uma planta, composição inseticida e construção de dna recombinante
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
WO2015017552A1
(en)
|
2013-08-01 |
2015-02-05 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to cd37 proteins
|
US9914775B2
(en)
|
2013-08-21 |
2018-03-13 |
The Board Of Regents Of The University Of Texas System |
Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels
|
ES2702674T3
(es)
|
2013-08-29 |
2019-03-04 |
Yeda Res & Dev |
Inhibidores selectivos de la isoforma alfa2 de Na,K-ATPasa y el uso para la reducción de la presión intraocular
|
SG10201907501QA
(en)
|
2013-08-30 |
2019-10-30 |
Immunogen Inc |
Antibodies and assays for detection of folate receptor 1
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
WO2015040609A1
(en)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Erk-derived peptides and uses thereof
|
AU2014330807B2
(en)
|
2013-10-01 |
2020-07-02 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of Amyotrophic Lateral Sclerosis (ALS)
|
EP3052193B1
(en)
|
2013-10-03 |
2018-01-31 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
PT3060239T
(pt)
|
2013-10-21 |
2020-08-26 |
Opko Biologics Ltd |
Polipéptidos de ação prolongada e métodos de produção e administração dos mesmos
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
RU2694950C2
(ru)
|
2013-11-04 |
2019-07-18 |
Монсанто Текнолоджи Ллс |
Композиции и способы для борьбы с членистоногими паразитами и заражениями вредителями
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
CA2930693A1
(en)
|
2013-11-15 |
2015-05-21 |
The Board Of Trustees Of The Leland Stanford Junior Unversity |
Methods of treating heart failure with agonists of hypocretin receptor 2
|
US20170336395A1
(en)
|
2013-11-20 |
2017-11-23 |
University Of Iowa Research Foundation |
Methods and compositions for treating amyloid deposits
|
ES2729406T3
(es)
|
2013-11-22 |
2019-11-04 |
Univ Illinois |
Receptores de linfocitos T humanos de alta afinidad modificados
|
CA2925698C
(en)
|
2013-11-28 |
2021-11-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
WO2015095604A2
(en)
|
2013-12-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Methods and assays relating to circulating tumor cells
|
CA2934039A1
(en)
|
2013-12-19 |
2015-06-25 |
Danisco Us Inc. |
Use of hydrophobins to increase gas transferin aerobic fermentation processes
|
US11293929B2
(en)
|
2014-01-07 |
2022-04-05 |
Bioatla, Inc. |
Proteins targeting orthologs
|
US10286058B2
(en)
|
2014-01-13 |
2019-05-14 |
Baylor Research Institute |
Vaccines against HPV and HPV-related diseases
|
BR112016016337A2
(pt)
|
2014-01-15 |
2017-10-03 |
Monsanto Technology Llc |
Composição e métodos para controlar crescimento, desenvolvimento ou a capacidade de reprodução de uma planta, e para sensibilizar uma planta para um herbicida inibidor de epsps
|
EP3099719B1
(en)
|
2014-01-29 |
2020-04-01 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
CA2937992A1
(en)
|
2014-02-03 |
2015-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of eliminating stem cells
|
US10125365B2
(en)
|
2014-02-05 |
2018-11-13 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
US10066014B2
(en)
|
2014-02-06 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Anti CD84 antibodies, compositions comprising same and uses thereof
|
WO2015120273A1
(en)
|
2014-02-07 |
2015-08-13 |
The General Hospital Corporation |
Differential diagnosis of hepatic neoplasms
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
US10564149B2
(en)
|
2014-02-11 |
2020-02-18 |
Brainstorm Cell Therapeutics Ltd. |
Populations of mesenchymal stem cells that secrete neurotrophic factors
|
WO2015123565A1
(en)
|
2014-02-14 |
2015-08-20 |
The General Hospital Corporation |
Methods for diagnosing igg4-related disease
|
US20150247205A1
(en)
|
2014-02-28 |
2015-09-03 |
The General Hospital Corporation |
Diagnosis of multiple myeloma and lymphoma
|
EP3114483A1
(en)
|
2014-03-03 |
2017-01-11 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
US11091770B2
(en)
|
2014-04-01 |
2021-08-17 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
WO2015155777A1
(en)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
CN106574296B
(zh)
|
2014-04-14 |
2021-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于测定dna的组织或细胞来源的方法和试剂盒
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
EA037613B1
(ru)
|
2014-04-27 |
2021-04-21 |
Фэймуэйв Лтд. |
Гуманизированные антитела против ceacam1
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
US20170071208A1
(en)
|
2014-05-04 |
2017-03-16 |
Forrest Innovations Ltd. |
Compositions for mosquito control and uses of same
|
EP3502698A1
(en)
|
2014-05-05 |
2019-06-26 |
MicroBPlex, Inc. |
Media elaborated with newly synthesized antibodies and uses thereof
|
EP3140653B1
(en)
|
2014-05-08 |
2022-05-11 |
Novodiax, Inc. |
Direct immunohistochemistry assay
|
WO2015179435A1
(en)
|
2014-05-19 |
2015-11-26 |
Bayer Healthcare Llc |
Optimized humanized monoclonal antibodies against activated protein c and uses thereof
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
EP3149155B1
(en)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
CN106795515B
(zh)
|
2014-06-23 |
2021-06-08 |
孟山都技术公司 |
用于经由rna干扰调控基因表达的组合物和方法
|
WO2015198320A1
(en)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
CA2953663A1
(en)
|
2014-06-25 |
2015-12-30 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification of cancer stem cells and use of same for diagnosis and treatment
|
EP3161138A4
(en)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
KR102569494B1
(ko)
|
2014-07-15 |
2023-08-21 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
Cd44의 단리된 폴리펩타이드 및 이의 사용
|
WO2016013007A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods for determining drug response of patient specific mutations
|
WO2016013008A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
US10378012B2
(en)
|
2014-07-29 |
2019-08-13 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
JP2017525351A
(ja)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
多能性幹細胞の培養用培地
|
AU2015296029B2
(en)
|
2014-08-01 |
2022-01-27 |
Dovetail Genomics, Llc |
Tagging nucleic acids for sequence assembly
|
WO2016024278A1
(en)
|
2014-08-14 |
2016-02-18 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
KR20170067729A
(ko)
|
2014-08-22 |
2017-06-16 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Cxcr3에 결합하는 항원 결합 단백질
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
JP2017534574A
(ja)
|
2014-09-08 |
2017-11-24 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
チロシンキナーゼ阻害薬(tki)に耐性のがんを処置するための組成物および方法
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
WO2016038609A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
US20180010132A1
(en)
|
2014-09-11 |
2018-01-11 |
Novartis Ag |
Inhibition of prmt5 to treat mtap-deficiency-related diseases
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
ES2804826T3
(es)
|
2014-09-16 |
2021-02-09 |
Synermore Biologics Co Ltd |
Anticuerpo anti-EGFR y usos del mismo
|
CN106999608A
(zh)
|
2014-09-21 |
2017-08-01 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
为了治疗脂质相关病症而下调mir‑132
|
RU2713653C2
(ru)
|
2014-10-06 |
2020-02-06 |
Кемосентрикс, Инк. |
КОМБИНИРОВАННАЯ ТЕРАПИЯ ИНГИБИТОРАМИ С-С ХЕМОКИНОВОГО РЕЦЕПТОРА 9 (CCR9) И АНТИТЕЛАМИ, БЛОКИРУЮЩИМИ α4β7-ИНТЕГРИН
|
US20170253921A1
(en)
|
2014-10-13 |
2017-09-07 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
GB2555995B
(en)
|
2014-10-20 |
2019-06-26 |
Gen Probe Inc |
Red blood cell lysis solution
|
EP3172329A1
(en)
|
2014-10-24 |
2017-05-31 |
Danisco US Inc. |
Method for producing alcohol by use of a tripeptidyl peptidase
|
AU2015334890B2
(en)
|
2014-10-24 |
2021-12-23 |
Dupont Nutrition Biosciences Aps |
Proline tolerant tripeptidyl peptidases and uses thereof
|
CN107406825B
(zh)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
甲壳纲十足目雌性动物的功能性别反转
|
WO2016079736A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
WO2016079731A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Method of analyzing microbiome
|
US11270782B2
(en)
|
2014-11-19 |
2022-03-08 |
Koninklijke Philips N.V. |
Diagnostic method employing HNL
|
WO2016079739A2
(en)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
|
CN107208070B
(zh)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金(以色列)有限合伙公司 |
细菌基因的靶向消除
|
WO2016084084A1
(en)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
EP3227446A1
(en)
|
2014-12-01 |
2017-10-11 |
Novartis AG |
Compositions and methods for diagnosis and treatment of prostate cancer
|
EP3754027A1
(en)
|
2014-12-01 |
2020-12-23 |
The Broad Institute, Inc. |
Methods for altering or modulating spatial proximity between nucleic acids inside of a cell
|
SG10202012249YA
(en)
|
2014-12-08 |
2021-01-28 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
JP6427278B2
(ja)
|
2014-12-23 |
2018-11-21 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
pirinポリペプチド及び免疫モジュレーション
|
EP3395351A1
(en)
|
2014-12-23 |
2018-10-31 |
4D Pharma Research Limited |
Immune modulation
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
JP2018502575A
(ja)
|
2014-12-30 |
2018-02-01 |
セル キュア ニューロサイエンシズ リミテッド |
網膜色素上皮細胞集団の評価法
|
JP6882981B2
(ja)
|
2014-12-30 |
2021-06-02 |
セル キュア ニューロサイエンシズ リミテッド |
Rpe細胞集団およびそれを作製する方法
|
EP3240612B1
(en)
|
2014-12-30 |
2020-12-23 |
Cell Cure Neurosciences Ltd. |
Methods of treating retinal diseases
|
RU2017125957A
(ru)
|
2015-01-04 |
2019-02-04 |
Проталикс Лтд. |
Модифицированная днказа и ее применения
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
CN108064288B
(zh)
|
2015-01-22 |
2021-11-26 |
孟山都技术公司 |
用于控制叶甲属的组合物和方法
|
EP3256490A1
(en)
|
2015-02-09 |
2017-12-20 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides displaying improved complement activation
|
JP6917902B2
(ja)
|
2015-02-13 |
2021-08-11 |
ソレント・セラピューティクス・インコーポレイテッド |
Ctla4に結合する抗体医薬
|
CN107533590B
(zh)
|
2015-02-17 |
2021-10-26 |
多弗泰尔基因组学有限责任公司 |
核酸序列装配
|
DK3262411T3
(da)
|
2015-02-25 |
2022-04-19 |
Univ Vanderbilt |
Antibody-mediated neutralization of marburg virus
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
BR112017019062A2
(pt)
|
2015-03-09 |
2018-04-17 |
Agensys Inc |
conjugados de anticorpo-fármaco (adc) que se ligam a proteínas flt3
|
CN107614700A
(zh)
|
2015-03-11 |
2018-01-19 |
布罗德研究所有限公司 |
基因型和表型偶联
|
WO2016142948A1
(en)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
US11807896B2
(en)
|
2015-03-26 |
2023-11-07 |
Dovetail Genomics, Llc |
Physical linkage preservation in DNA storage
|
AU2016243124A1
(en)
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cell therapy directed to LHR for the treatment of solid tumors
|
EP4218771A1
(en)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods of treating motor neuron diseases
|
CA2979309A1
(en)
|
2015-03-31 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations and methods of generating same and uses thereof
|
US9612534B2
(en)
|
2015-03-31 |
2017-04-04 |
Tokyo Electron Limited |
Exposure dose homogenization through rotation, translation, and variable processing conditions
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
HUE057044T2
(hu)
|
2015-04-07 |
2022-04-28 |
Ela Pharma Ltd |
Sejt- vagy szövetnekrózis kezelésére és/vagy megelõzésére szolgáló, katepszin C-t és/vagy CELA1-et és/vagy CELA3A-t és/vagy szerkezetileg rokon enzimeket specifikusan targetáló készítmények
|
ES2927119T3
(es)
|
2015-04-08 |
2022-11-02 |
Sorrento Therapeutics Inc |
Productos terapéuticos de anticuerpos que se unen a CD38
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
AU2016255725B2
(en)
|
2015-04-27 |
2021-09-23 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
EP3288386B1
(en)
|
2015-04-29 |
2022-01-19 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Anti-phytopathogenic compositions
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
WO2016178207A1
(en)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
WO2016182984A1
(en)
|
2015-05-08 |
2016-11-17 |
Centrillion Technology Holdings Corporation |
Disulfide-linked reversible terminators
|
WO2016181393A1
(en)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Citrin inhibitors for the treatment of cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
CA2986203A1
(en)
|
2015-05-21 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
EP3302571B1
(en)
|
2015-05-29 |
2020-11-18 |
OPKO Biologics Ltd. |
Pegylated oxyntomodulin variants
|
EP3302053B1
(en)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions and methods for delivery of a polynucleotide into a plant
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
EP3302559B1
(en)
|
2015-06-04 |
2022-01-12 |
University of Southern California |
Lym-1 and lym-2 targeted car cell immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
PT3650033T
(pt)
|
2015-06-15 |
2022-05-25 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
CN107847529B
(zh)
|
2015-06-15 |
2022-05-03 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
BR112017025005A2
(pt)
|
2015-06-15 |
2018-08-07 |
4D Pharma Research Limited |
composições compreendendo cepas baterianas
|
EP4026563A1
(en)
|
2015-06-18 |
2022-07-13 |
Yeda Research and Development Co. Ltd |
Conditioning protocols and use of same for tissue regeneration
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
CN113289009A
(zh)
|
2015-06-19 |
2021-08-24 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
MX2017016501A
(es)
|
2015-06-26 |
2018-03-12 |
Dupont Nutrition Biosci Aps |
Aminopeptidasas para hidrolizados de proteinas.
|
AU2016291558A1
(en)
|
2015-07-10 |
2018-02-08 |
West Virginia University |
Markers of stroke and stroke severity
|
CN114457039A
(zh)
|
2015-07-16 |
2022-05-10 |
耶达研究及发展有限公司 |
基因修饰的抗第三方中央型记忆t细胞及其在免疫疗法中的用途
|
AU2016291817A1
(en)
|
2015-07-16 |
2018-02-22 |
Biolinerx Ltd. |
Compositions and methods for treating cancer
|
WO2017013648A1
(en)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE
|
WO2017015334A1
(en)
|
2015-07-21 |
2017-01-26 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
MX2018000844A
(es)
|
2015-07-22 |
2018-07-06 |
Phytopharma Int Ltd |
Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera.
|
WO2017017686A1
(en)
|
2015-07-29 |
2017-02-02 |
Hadasit Medical Research Services And Development Ltd. |
Large scale production of retinal pigment epithelial cells
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
CA2994416A1
(en)
|
2015-08-04 |
2017-02-09 |
Cd Diagnostics, Inc. |
Methods for detecting adverse local tissue reaction (altr) necrosis
|
EP3332009A1
(en)
|
2015-08-04 |
2018-06-13 |
Yeda Research and Development Co., Ltd. |
Methods of screening for riboswitches and attenuators
|
EP3331995A1
(en)
|
2015-08-05 |
2018-06-13 |
Cell Cure Neurosciences Ltd. |
Preparation of photoreceptors for the treatment of retinal diseases
|
EP4155391A1
(en)
|
2015-08-05 |
2023-03-29 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
EP3331549B1
(en)
|
2015-08-06 |
2020-12-23 |
President and Fellows of Harvard College |
Improved microbe-binding molecules and uses thereof
|
EP3334449B1
(en)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
EP3334831A1
(en)
|
2015-08-13 |
2018-06-20 |
Forrest Innovations Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
AU2016308339A1
(en)
|
2015-08-18 |
2018-04-12 |
Baylor College Of Medicine |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
WO2017033152A1
(en)
|
2015-08-25 |
2017-03-02 |
Prothena Biosciences Limited |
Methods for detecting phosphorylated alpha-synuclein
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
CA3035810A1
(en)
|
2015-09-02 |
2017-03-09 |
University Of Massachusetts |
Detection of gene loci with crispr arrayed repeats and/or polychromatic single guide ribonucleic acids
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
CA3036409C
(en)
|
2015-09-08 |
2023-07-11 |
Erik J. Sontheimer |
Dnase h activity of neisseria meningitidis cas9
|
WO2017042816A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation of perforin positive dendritic cells in cancer treatment
|
EP3353547A1
(en)
|
2015-09-22 |
2018-08-01 |
Delta TM Technologies |
Designing customized protein-specific buffer systems
|
US11384399B2
(en)
|
2015-09-29 |
2022-07-12 |
Htg Molecular Diagnostics, Inc. |
Methods for subtyping diffuse large B-cell lymphoma (DLBCL)
|
US20190062394A1
(en)
|
2015-10-10 |
2019-02-28 |
Intrexon Corporation |
Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12
|
CN108368543B
(zh)
|
2015-10-12 |
2023-06-13 |
领先细胞医疗诊断有限公司 |
高噪声样品中原位检测核苷酸变体及相关的组合物和方法
|
CN108368542B
(zh)
|
2015-10-19 |
2022-04-08 |
多弗泰尔基因组学有限责任公司 |
用于基因组组装、单元型定相以及独立于靶标的核酸检测的方法
|
WO2017072757A1
(en)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
AU2016347652A1
(en)
|
2015-10-26 |
2018-05-24 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3187317A1
(en)
|
2015-10-27 |
2017-05-04 |
Jay Pharma, Inc. |
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
WO2017077539A1
(en)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
FI3373968T3
(fi)
|
2015-11-09 |
2024-07-17 |
Childrens Hospital Philadelphia |
Glypikaani 2 syövän merkkiaineena ja terapeuttisena kohteena
|
EP3374524A4
(en)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
PROCESS FOR DETECTION OF 5-HYDROXYMETHYLCYTOSINE AND FOR DIAGNOSIS OF CANCER
|
MA41013A
(fr)
|
2015-11-20 |
2017-08-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
WO2017094001A1
(en)
|
2015-11-30 |
2017-06-08 |
Kadimastem Ltd |
Methods for differentiating and purifying pancreatic endocrine cells
|
MX2018006613A
(es)
|
2015-12-02 |
2019-01-30 |
Stcube & Co Inc |
Anticuerpos y moleculas que se unen inmunoespecificamente a btn1a1 y los usos terapeuticos de los mismos.
|
JP7227007B2
(ja)
|
2015-12-02 |
2023-02-21 |
ストサイエンシス, インコーポレイテッド |
グリコシル化btla(b-及びt-リンパ球減弱因子)に特異的な抗体
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
EP3383418B1
(en)
|
2015-12-04 |
2021-10-20 |
Board of Regents, The University of Texas System |
Slc45a2 peptides for immunotherapy
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
JOP20200228A1
(ar)
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
EP3393524B1
(en)
|
2015-12-22 |
2022-04-06 |
The Regents of The University of Colorado, A Body Corporate |
Protecting rnas from degradation using engineered viral rnas
|
IL260331B1
(en)
|
2015-12-28 |
2024-06-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Compounds and methods for the treatment of amyotrophic lateral sclerosis
|
EP3400068A1
(en)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
WO2017122203A1
(en)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
WO2017125931A1
(en)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Parthenocarpic plants and methods of producing same
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
US10118963B2
(en)
|
2016-01-29 |
2018-11-06 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind PD-L1
|
WO2017130205A1
(en)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
WO2017134671A1
(en)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
US10036011B2
(en)
|
2016-02-11 |
2018-07-31 |
Qiagen Waltham, Inc. |
Scavenger compounds for improved sequencing-by-synthesis
|
CN109196113B
(zh)
|
2016-02-11 |
2022-10-04 |
奇根科学有限责任公司 |
合成测序中的多酚添加剂
|
ES2771223T3
(es)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
MX2018009984A
(es)
|
2016-02-16 |
2019-01-21 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Análogos no proteínicos de fenilananina para la inhibicion del crecimiento de cianobacterias y plantas.
|
US20200200735A9
(en)
|
2016-02-22 |
2020-06-25 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
US10975417B2
(en)
|
2016-02-23 |
2021-04-13 |
Dovetail Genomics, Llc |
Generation of phased read-sets for genome assembly and haplotype phasing
|
JP2019511919A
(ja)
|
2016-02-23 |
2019-05-09 |
ブローディ,チャヤ |
がん幹細胞の作製およびその使用
|
MX2018009216A
(es)
|
2016-02-25 |
2018-11-09 |
Dupont Nutrition Biosci Aps |
Metodo para producir un hidrolizado de proteina empleando una tripeptidil peptidasa de aspergillus fumigatus.
|
AU2017224122B2
(en)
|
2016-02-26 |
2024-04-11 |
The Board Of Regents Of The University Of Texas System |
Connexin (Cx) 43 hemichannel-binding antibodies and uses thereof
|
IL296874A
(en)
|
2016-03-01 |
2022-11-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Antibodies specific for the human poliovirus receptor
|
WO2017149547A1
(en)
|
2016-03-03 |
2017-09-08 |
Memed Diagnostics Ltd. |
Analyzing rna for diagnosing infection type
|
EA035949B1
(ru)
|
2016-03-04 |
2020-09-04 |
4Д ФАРМА ПиЭлСи |
Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
CN109462996A
(zh)
|
2016-03-17 |
2019-03-12 |
西达-赛奈医疗中心 |
通过rnaset2诊断炎性肠病的方法
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
EP3433262A4
(en)
|
2016-03-25 |
2019-11-20 |
Muralidhar Reddy Moola |
COMBINATORY SYNTHESIS AND DEVELOPMENT OF BIOMARKERS
|
CN109195991B
(zh)
|
2016-03-29 |
2023-10-31 |
斯特库比股份有限公司 |
对糖基化pd-l1特异的双重功能抗体及其使用方法
|
CN109195990A
(zh)
|
2016-03-30 |
2019-01-11 |
Musc研究发展基金会 |
通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法
|
DE202017007130U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Inc. |
Lysereagenz für Blutzellen
|
WO2017194589A1
(en)
|
2016-05-10 |
2017-11-16 |
Vib Vzw |
Inhibition of tau-mediated early synaptic dysfunction
|
SG11201810088SA
(en)
|
2016-05-13 |
2018-12-28 |
Dovetail Genomics Llc |
Recovering long-range linkage information from preserved samples
|
AU2017268248A1
(en)
|
2016-05-16 |
2018-12-13 |
President And Fellows Of Harvard College |
Aqueous biomolecule coupling on CO2-plasma-activated surfaces
|
ES2886627T3
(es)
|
2016-05-22 |
2021-12-20 |
Yeda Res & Dev |
Métodos de uso de células pulmonares para trasplante e inducción de tolerancia
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
EP3464322B1
(en)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Novel molecules for the treatment of inflammation
|
WO2017214068A1
(en)
|
2016-06-05 |
2017-12-14 |
Berg Llc |
Systems and methods for patient stratification and identification of potential biomarkers
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(en)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
JP7334043B2
(ja)
|
2016-06-27 |
2023-08-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
メモリーt細胞から作られるベト細胞
|
CN109416357B
(zh)
|
2016-06-30 |
2022-07-15 |
西门子医疗系统荷兰有限公司 |
用于检测包含多个细胞的体液样本中的分析物的设备、系统和方法
|
CN109661578B
(zh)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
用于区分细菌和病毒感染的蛋白质特征
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
CN109689893A
(zh)
|
2016-07-11 |
2019-04-26 |
博纳斯治疗公司 |
用于组织再生的细胞组合物
|
CN118085104A
(zh)
|
2016-07-11 |
2024-05-28 |
Opko生物科学有限公司 |
长效凝血因子及其制备方法
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
IL291373B2
(en)
|
2016-07-11 |
2023-10-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods and systems for growing cells in culture
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
EP4434516A2
(en)
|
2016-07-18 |
2024-09-25 |
Ramot at Tel-Aviv University Ltd. |
Modular platform for targeted therapeutics
|
WO2018017673A1
(en)
|
2016-07-20 |
2018-01-25 |
Stcube, Inc. |
Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated pd-l1
|
AU2017300579B2
(en)
|
2016-07-20 |
2023-02-09 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Therapeutic agents for neurological and psychiatric disorders
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP4033248B1
(en)
|
2016-08-10 |
2024-04-10 |
MeMed Diagnostics Ltd. |
System and method for analysis of mx1 and crp in blood
|
EP3497239A4
(en)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
METHYLATION STATUS ANALYSIS AND COPY NUMBER
|
IL264825B
(en)
|
2016-08-14 |
2022-08-01 |
Univ Ramot |
Exosomes from mesenchymal cells for the treatment of neurological diseases
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
EP3510047A1
(en)
|
2016-09-07 |
2019-07-17 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
WO2018060998A1
(en)
|
2016-09-29 |
2018-04-05 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
WO2018085679A1
(en)
|
2016-11-04 |
2018-05-11 |
Stave James W |
Direct detection of microorganisms in patient samples by immunoassay
|
EP3538093B1
(en)
|
2016-11-09 |
2023-10-25 |
Qiagen Sciences, LLC |
Photoprotective mixtures as imaging reagents in sequencing-by-synthesis
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
MX2021014356A
(es)
|
2016-11-23 |
2022-11-24 |
Chemocentryx Inc |
Metodo para tratar glomeruloesclerosis segmentaria focal.
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
CN110199031A
(zh)
|
2016-11-29 |
2019-09-03 |
基因组影像公司 |
设计用于分析感兴趣的遗传区域中的特定事件的一组多核苷酸序列的方法
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
EP3548106B1
(en)
|
2016-12-01 |
2023-01-04 |
Ramot at Tel-Aviv University Ltd. |
Combined treatment for nerve injuries
|
EP3329905A1
(en)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
|
ES2932498T3
(es)
|
2016-12-05 |
2023-01-20 |
Nuritas Ltd |
Composiciones que comprenden el péptido WKDEAGKPLVK
|
EP3329930A1
(en)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Pharmaceuctical compositions
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
EP3571295A1
(en)
|
2017-01-18 |
2019-11-27 |
Yeda Research and Development Co. Ltd |
Genetically modified veto cells and use of same in immunotherapy
|
CA3051512A1
(en)
|
2017-01-26 |
2018-08-02 |
Zlip Holding Limited |
Cd47 antigen binding unit and uses thereof
|
US20190390278A1
(en)
|
2017-01-26 |
2019-12-26 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
AU2018214946A1
(en)
|
2017-01-31 |
2019-08-08 |
Vanderbilt University |
Generation of human allergen-and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
WO2018146162A1
(en)
|
2017-02-07 |
2018-08-16 |
Academisch Medisch Centrum |
Molecular biomarker for prognosis of sepsis patients
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
EP3592868B1
(en)
|
2017-03-06 |
2022-11-23 |
Novartis AG |
Methods of treatment of cancer with reduced ubb expression
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
EP3596469A1
(en)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
IL269363B2
(en)
|
2017-03-16 |
2024-02-01 |
Lineage Cell Therapeutics Inc |
Methods for measuring medical effects of treating retinal diseases
|
FI3607050T3
(fi)
|
2017-04-05 |
2023-11-20 |
Yeda Res & Dev |
Ex vivo viljelyjärjestelmä ja menetelmiä sen käyttämiseksi
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
US12091445B2
(en)
|
2017-05-10 |
2024-09-17 |
Ariel Scientific Innovations Ltd. |
Methods of purifying antibodies
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
MA48939B1
(fr)
|
2017-05-22 |
2021-06-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2018216011A1
(en)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
WO2018215782A1
(en)
|
2017-05-24 |
2018-11-29 |
4D Pharma Research Limited |
Compositions comprising bacterial strain
|
JP2020522512A
(ja)
|
2017-05-31 |
2020-07-30 |
ストキューブ アンド シーオー., インコーポレイテッド |
Btn1a1に免疫特異的に結合する抗体及び分子を用いて癌を治療する方法
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018220582A1
(en)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
WO2018222689A1
(en)
|
2017-05-31 |
2018-12-06 |
Stcube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
US11542331B2
(en)
|
2017-06-06 |
2023-01-03 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
LT3638271T
(lt)
|
2017-06-14 |
2021-01-11 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterines padermes
|
HUE053488T2
(hu)
|
2017-06-14 |
2021-06-28 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
MD3600364T2
(ro)
|
2017-06-14 |
2020-12-31 |
4D Pharma Res Ltd |
Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora
|
EP3652343A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Dual-probe digital droplet pcr strategy for specific detection of tissue-specific circulating dna molecules
|
EP3652344A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Dna targets as tissue-specific methylation markers
|
EP3652342A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Detecting tissue-specific dna
|
WO2019018747A1
(en)
|
2017-07-20 |
2019-01-24 |
Trustees Of Boston University |
DETECTION ASSAY OF TENOFOVIR
|
US11530413B2
(en)
|
2017-07-21 |
2022-12-20 |
Novartis Ag |
Compositions and methods to treat cancer
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
CN111094352A
(zh)
|
2017-08-25 |
2020-05-01 |
戊瑞治疗有限公司 |
B7-h4抗体及其使用方法
|
WO2019042153A1
(zh)
|
2017-09-01 |
2019-03-07 |
四川科伦博泰生物医药股份有限公司 |
重组双特异性抗体
|
US11981723B2
(en)
|
2017-09-05 |
2024-05-14 |
GLAdiator Biosciences, Inc. |
Method of targeting exosomes
|
US11464784B2
(en)
|
2017-09-15 |
2022-10-11 |
The Regents Of The University Of California |
Inhibition of aminocylase 3 (AA3) in the treatment of cancer
|
EP3684929A1
(en)
|
2017-09-19 |
2020-07-29 |
Tropic Biosciences UK Limited |
Modifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
|
EP3692152A4
(en)
|
2017-10-04 |
2021-12-01 |
The Broad Institute, Inc. |
PROCESSES AND COMPOSITIONS FOR MODIFYING THE FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND / OR DOMAINS
|
WO2019075086A1
(en)
|
2017-10-11 |
2019-04-18 |
Chemocentryx, Inc. |
TREATMENT OF FOCAL SEGMENTAL GLOBEROSCLEROSIS WITH CCR2 ANTAGONISTS
|
EP3694545A4
(en)
|
2017-10-11 |
2021-12-01 |
Board Of Regents, The University Of Texas System |
HUMAN PD-L1 ANTIBODIES AND METHOD OF USING THEM
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
WO2019106667A1
(en)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits and methods for controlling weed of the amaranthus genus
|
EP3717032B1
(en)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
CN109870581B
(zh)
|
2017-12-04 |
2021-05-04 |
厦门万泰凯瑞生物技术有限公司 |
一种定量检测HBsAg的试剂盒及方法
|
EP3723786A4
(en)
|
2017-12-15 |
2021-09-08 |
Syngenta Participations Ag |
NON-ANTIBODY LIGANDS FOR DETECTION OF TARGET PROTEINS
|
EP3723785A1
(en)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Cop9 signalosome (csn) complex modulators and uses thereof
|
WO2019130313A1
(en)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
WO2019156758A2
(en)
|
2018-01-05 |
2019-08-15 |
Vanderbilt University |
Antibody-mediated neutralization of chikungunya virus
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
WO2019155459A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibitors of the 20s proteasome
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
US20200408771A1
(en)
|
2018-02-22 |
2020-12-31 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Cd153 and/or cd30 in infection
|
WO2019162945A1
(en)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
AU2019228600A1
(en)
|
2018-03-02 |
2020-09-24 |
Five Prime Therapeutics, Inc. |
B7-H4 antibodies and methods of use thereof
|
WO2019175869A1
(en)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Treatment of a heart disease
|
US20210214445A1
(en)
|
2018-03-23 |
2021-07-15 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
EP3774047A1
(en)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Use of electric field gradients to control gene expression
|
WO2019186558A1
(en)
|
2018-03-29 |
2019-10-03 |
Technion Research And Development Foundation Limited |
Vesicles comprising a pten inhibitor and uses of same
|
EP4063519B1
(en)
|
2018-04-09 |
2023-09-13 |
Advanced Cell Diagnostics, Inc. |
Methods to further enhance signal amplification for the in situ detection of nucleic acids
|
US11884725B2
(en)
|
2018-04-24 |
2024-01-30 |
Ampsource Biopharma Shanghai Inc. |
Antibody against TIM-3 and application thereof
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
EP3788138A1
(en)
|
2018-05-02 |
2021-03-10 |
Novartis AG |
Regulators of human pluripotent stem cells and uses thereof
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
US20210121491A1
(en)
|
2018-05-27 |
2021-04-29 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
US11827892B2
(en)
|
2018-06-07 |
2023-11-28 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
CA3102975A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
US20210238229A1
(en)
|
2018-06-14 |
2021-08-05 |
University College Cork - National University Of Ireland, Cork |
Peptide for disease treatment
|
WO2019244107A1
(en)
|
2018-06-21 |
2019-12-26 |
Daiichi Sankyo Company, Limited |
Compositions including cd3 antigen binding fragments and uses thereof
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
EP3814385A4
(en)
|
2018-07-11 |
2022-04-06 |
KAHR Medical Ltd. |
SIRPALPHA-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
CN112351989B
(zh)
|
2018-07-11 |
2024-03-26 |
免疫制药有限公司 |
肽化合物及其治疗用途
|
JP7479343B2
(ja)
|
2018-07-31 |
2024-05-08 |
コルプラント リミテッド |
タバコのトランスジェニックイベント、並びにその検出方法およびその使用
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020039440A1
(en)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Methods of modulating m2 macrophage polarization and use of same in therapy
|
EP3849608B1
(en)
|
2018-09-13 |
2023-08-30 |
The Board of Regents of The University of Texas System |
Novel lilrb4 antibodies and uses thereof
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
WO2020069424A1
(en)
|
2018-09-28 |
2020-04-02 |
Centrillion Technologies, Inc. |
Disulfide-linked reversible terminators
|
EA202191033A1
(ru)
|
2018-10-15 |
2021-12-21 |
Юниверсити Оф Массачусетс |
Программируемое редактирование оснований днк посредством слитых белков nme2cas9-дезаминаза
|
CA3116539C
(en)
|
2018-10-18 |
2023-10-03 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
CN112912396B
(zh)
|
2018-10-22 |
2023-03-14 |
上海吉倍生物技术有限公司 |
抗cldn18.2抗体及其用途
|
SG11202103124WA
(en)
|
2018-10-23 |
2021-04-29 |
Glycardial Diagnostics S L |
Antibodies specific for glycosylated apoj and uses thereof
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
CN111196851B
(zh)
|
2018-11-20 |
2021-11-16 |
厦门万泰凯瑞生物技术有限公司 |
针对人抗缪勒管激素的特异性抗体及其应用
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
US20220089776A1
(en)
|
2018-11-28 |
2022-03-24 |
Oregon Health & Science University |
Therapeutic factor xii antibody
|
EP4369356A3
(en)
|
2018-11-30 |
2024-07-24 |
Caris MPI, Inc. |
Next-generation molecular profiling
|
EP3904386A4
(en)
|
2018-12-28 |
2022-09-07 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
ANTIBODIES AND USE THEREOF
|
EP3914698A1
(en)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Culture media for pluripotent stem cells
|
WO2020185312A2
(en)
|
2019-01-25 |
2020-09-17 |
President And Fellows Of Harvard College |
Compositions and method for synthesizing nucleic acids
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
EP3924501A4
(en)
|
2019-02-15 |
2022-11-23 |
Advanced Cell Diagnostics, Inc. |
METHODS FOR MULTIPLEX DETECTION OF NUCLEIC ACIDS BY IN SITU HYBRIDIZATION
|
WO2020170240A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
EP3927807A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
WO2020178822A1
(en)
|
2019-03-05 |
2020-09-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Genome-edited birds
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
WO2020202142A2
(en)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
JP2022528595A
(ja)
|
2019-04-16 |
2022-06-15 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗FXI/FXIa抗体及びその使用
|
CA3138566A1
(en)
|
2019-04-30 |
2020-11-05 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
WO2020234888A1
(en)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
IT201900007222A1
(it)
|
2019-05-24 |
2020-11-24 |
Univ Degli Studi Di Torino |
Composizione di liposomi e metodo di dosaggio basato sull'uso degli stessi
|
CN114599675B
(zh)
|
2019-05-28 |
2024-08-16 |
上海科技大学 |
用于治疗clouston型外胚层发育不良2的组合物和方法
|
EP3983531A1
(en)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Methods of generating oligodendrocytes
|
WO2020255124A1
(en)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
AU2020302791A1
(en)
|
2019-06-27 |
2022-02-03 |
Dovetail Genomics, Llc |
Methods and compositions for proximity ligation
|
WO2020261281A1
(en)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
EP3994268A1
(en)
|
2019-07-04 |
2022-05-11 |
Ukko Inc. |
De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
|
WO2021005599A1
(en)
|
2019-07-11 |
2021-01-14 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
AU2020317009A1
(en)
|
2019-07-19 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors containing Glypican 2 binding domains
|
EP4004037A1
(en)
|
2019-07-26 |
2022-06-01 |
Vanderbilt University |
Human monoclonal antibodies to enterovirus d68
|
EP4004548A1
(en)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Methods of treating and diagnosing lung cancer
|
EP4004212A1
(en)
|
2019-07-30 |
2022-06-01 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
EP4014046A1
(en)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
EP3783012A1
(en)
|
2019-08-20 |
2021-02-24 |
Nuritas Limited |
An antimicrobial peptide
|
EP4017518A1
(en)
|
2019-08-20 |
2022-06-29 |
Nuritas Limited |
Peptides for treating muscle atrophy
|
WO2021033176A1
(en)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(en)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
US20220331363A1
(en)
|
2019-09-20 |
2022-10-20 |
Shanghai GenBase Biotechnology Co., Ltd. |
Bcma-targeted antibody and chimeric antigen receptor
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
EP4041767A1
(en)
|
2019-09-26 |
2022-08-17 |
StCube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
JP2022550243A
(ja)
|
2019-09-30 |
2022-12-01 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗pd-1抗体及びその使用
|
JP2022552282A
(ja)
|
2019-10-09 |
2022-12-15 |
エスティーキューブ アンド カンパニー |
グリコシル化lag3に対して特異的な抗体およびその使用方法
|
WO2021078912A1
(en)
|
2019-10-22 |
2021-04-29 |
Nuritas Limited |
Treatment of non-alcoholic fatty liver disease
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
WO2021095031A2
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
IL293148A
(en)
|
2019-11-19 |
2024-07-01 |
Protalix Ltd |
Removal of constructs from transduced cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
US10792360B1
(en)
|
2019-11-21 |
2020-10-06 |
Chemocentryx, Inc. |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
|
JP2023504270A
(ja)
|
2019-12-02 |
2023-02-02 |
カリス エムピーアイ インコーポレイテッド |
汎がんのプラチナ反応予測子
|
CN115176027A
(zh)
|
2019-12-12 |
2022-10-11 |
哈佛大学校长及研究员协会 |
用于光指导的生物分子条形码化的组合物和方法
|
JP2023505408A
(ja)
|
2019-12-13 |
2023-02-09 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗tslp抗体及びその使用
|
KR20220143005A
(ko)
|
2019-12-20 |
2022-10-24 |
노바록 바이오테라퓨틱스 리미티드 |
항-인터루킨-23 p19 항체 및 이의 사용 방법
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021130753A1
(en)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnosis of frontotemporal dementia
|
EP3842452A1
(en)
|
2019-12-26 |
2021-06-30 |
Universitat Autònoma de Barcelona |
Scaffold proteins and therapeutic nanoconjugates based on nidogen
|
WO2021137230A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137231A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
CN113061165A
(zh)
|
2020-01-02 |
2021-07-02 |
厦门大学 |
EB病毒BNLF2b基因编码多肽及其检测用途
|
IL272074B1
(en)
|
2020-01-15 |
2024-08-01 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
WO2021152587A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
BR102020002165A2
(pt)
|
2020-01-31 |
2021-11-30 |
Fundação Oswaldo Cruz |
Anticorpo, seu uso, composição farmacêutica o compreendendo, método de diagnóstico de infecções fúngicas, kit de diagnóstico de infecções fúngicas e método para tratamento de infecções fúngicas.
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
EP3862014A1
(en)
|
2020-02-07 |
2021-08-11 |
Nuritas Limited |
Treatment of panx1 associated diseases
|
KR20220151168A
(ko)
|
2020-02-09 |
2022-11-14 |
엔엘씨 파르마 엘티디 |
Sars-cov-2에 대한 신속한 검출 테스트
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
KR20220140568A
(ko)
|
2020-02-11 |
2022-10-18 |
벤더르빌트 유니버시티 |
중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 인간 단일클론 항체
|
WO2021167908A1
(en)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Methods for expansion of tumor infiltrating lymphocytes and use thereof
|
EP4110794A1
(en)
|
2020-02-25 |
2023-01-04 |
Vib Vzw |
Leucine-rich repeat kinase 2 allosteric modulators
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
WO2021186431A1
(en)
|
2020-03-16 |
2021-09-23 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
|
PT4045533T
(pt)
|
2020-03-26 |
2024-02-14 |
Univ Vanderbilt |
Anticorpos monoclonais humanos para síndrome respiratória aguda grave coronavírus 2 (sars-cov-2)
|
WO2021195385A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-GoV-2)
|
EP4126226A1
(en)
|
2020-03-29 |
2023-02-08 |
Yeda Research and Development Co. Ltd |
Variants of beta-glucocerebrosidase for use in treating gaucher disease
|
EP4125440A1
(en)
|
2020-03-31 |
2023-02-08 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
TW202203916A
(zh)
|
2020-03-31 |
2022-02-01 |
美商卡默森屈有限公司 |
使用ccr9抑制劑及抗il—23阻斷抗體治療發炎性腸道疾病的組成物及方法
|
EP4133107A1
(en)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
EP4132479A1
(en)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
AU2021255132A1
(en)
|
2020-04-13 |
2022-12-08 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type P53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
EP4139456A4
(en)
|
2020-04-22 |
2024-05-22 |
President And Fellows Of Harvard College |
ISOTHERMAL METHODS, COMPOSITIONS, KITS AND SYSTEMS FOR THE DETECTION OF NUCLEIC ACIDS
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
MX2022014332A
(es)
|
2020-05-15 |
2022-12-13 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Conjugado anticuerpo-farmaco, metodo de preparacion del mismo y uso del mismo.
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
CN115803062A
(zh)
|
2020-06-03 |
2023-03-14 |
博泰康医药公司 |
滋养层细胞表面抗原2(trop-2)抗体
|
EP4168438A4
(en)
|
2020-06-22 |
2024-07-10 |
Univ Ramot |
MULTIPLE SUBUNIT PROTEIN MODULES, CELLS FOR EXPRESSING THEM AND USES THEREOF
|
WO2021260675A1
(en)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
EP3939999A1
(en)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
WO2022047359A1
(en)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Protein biomarkers for pancreatic cancer
|
JP2023540526A
(ja)
|
2020-09-04 |
2023-09-25 |
ノヴァロック バイオセラピューティクス, リミテッド |
ネクチン-4抗体およびそれの使用
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(en)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
KR20230113283A
(ko)
|
2020-10-05 |
2023-07-28 |
프로탈릭스 리미티드 |
다이서-유사 넉아웃 식물 세포
|
WO2022074656A1
(en)
|
2020-10-07 |
2022-04-14 |
Protalix Ltd. |
Long-acting dnase
|
EP4228637A1
(en)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
EP4240856A2
(en)
|
2020-11-09 |
2023-09-13 |
1E Therapeutics, Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
GB202105804D0
(en)
|
2020-11-20 |
2021-06-09 |
Univ Cape Town |
Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
|
WO2022115498A1
(en)
|
2020-11-26 |
2022-06-02 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
CA3200167A1
(en)
|
2020-12-04 |
2022-06-09 |
Jonathan S. Wall |
Method for diagnosing amyloid diseases
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
IL304047A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
Silencing target sites in the p21 mRNA sequence
|
IL304068A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
DNA enzymes against p21 messenger RNA
|
CA3203886A1
(en)
|
2020-12-31 |
2022-07-07 |
Yanni CONG |
Human lifr antigen binding protein, preparation method therefor, and application thereof
|
WO2022149142A2
(en)
|
2021-01-10 |
2022-07-14 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
CN116917326A
(zh)
|
2021-01-22 |
2023-10-20 |
博泰康医药公司 |
抗her-2/trop-2构建体及其用途
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
WO2022170971A1
(zh)
|
2021-02-09 |
2022-08-18 |
苏州宜联生物医药有限公司 |
生物活性物偶联物及其制备方法和用途
|
IL305314A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
A genetically engineered bacterium for vaccine production
|
JP2024506955A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチンを作製する方法
|
CA3211270A1
(en)
|
2021-02-19 |
2022-08-25 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
EP4302777A1
(en)
|
2021-03-05 |
2024-01-10 |
Shanghai Genbase Biotechnology Co., Ltd. |
Anti-cldn6 antibody and use thereof
|
CN117729942A
(zh)
|
2021-03-08 |
2024-03-19 |
伊缪诺金公司 |
用于增加靶向adam9的免疫缀合物治疗癌症的功效的方法
|
CA3207635A1
(en)
|
2021-03-09 |
2022-09-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Ror1 binding protein and use thereof
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(en)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
IL307530A
(en)
|
2021-04-06 |
2023-12-01 |
Bpgbio Inc |
Estrogen receptor-like (ER) breast cancer protein markers LUMINAL A (LA) and LUMINAL B1 (LB1)
|
CA3214833A1
(en)
|
2021-04-06 |
2022-10-13 |
Bpgbio, Inc. |
Protein markers for the prognosis of breast cancer progression
|
CN118661103A
(zh)
|
2021-04-06 |
2024-09-17 |
布普格生物制药公司 |
雌激素受体(er)阳性样和雌激素受体(er)阴性样乳腺癌的蛋白质标志物
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
CN117651564A
(zh)
|
2021-04-14 |
2024-03-05 |
爱尔兰国立科克大学 |
脑血管事件和神经系统疾病的治疗
|
AU2022259568A1
(en)
|
2021-04-14 |
2023-11-09 |
University College Cork - National University Of Ireland, Cork |
Psg1 for use in the treatment of osteoarthritis
|
CA3215979A1
(en)
|
2021-04-19 |
2022-10-27 |
Ghassan SAED |
Methods for detecting or treating endometrial and ovarian hyperproliferative disorders
|
JP2024520907A
(ja)
|
2021-05-12 |
2024-05-27 |
バイオエムエックス・リミテッド |
ブドウ球菌バクテリオファージ及びその使用
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
CA3219233A1
(en)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Combined treatment for cancer
|
IL309333A
(en)
|
2021-06-13 |
2024-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
A method for reprogramming cells
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
KR20240035997A
(ko)
|
2021-06-16 |
2024-03-19 |
시드엑스 테크놀로지스 인코포레이티드 |
마티올라 종자들을 선별하는 방법들
|
CA3223344A1
(en)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
WO2023288046A1
(en)
|
2021-07-15 |
2023-01-19 |
President And Fellows Of Harvard College |
Compositions and methods relating to cells with adhered particles
|
JP2024526837A
(ja)
|
2021-07-18 |
2024-07-19 |
ガミダ セル リミテッド |
治療用nk細胞集団
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
EP4377352A2
(en)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
EP4380973A2
(en)
|
2021-08-02 |
2024-06-12 |
Yeda Research and Development Co. Ltd. |
Anti-matrix metalloproteinase-14 antibodies for the treatment of cancer
|
EP4380966A2
(en)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
WO2023018621A1
(en)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
CA3236778A1
(en)
|
2021-11-02 |
2023-05-11 |
Erik SONTHEIMER |
Nme2cas9 inlaid domain fusion proteins
|
AU2022392804A1
(en)
|
2021-11-19 |
2024-05-02 |
Mirobio Limited |
Engineered PD-1 antibodies and uses thereof
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
TW202334206A
(zh)
|
2022-01-25 |
2023-09-01 |
大陸商蘇州宜聯生物醫藥有限公司 |
一種針對Her3的抗體、偶聯物及其用途
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
AU2023214198A1
(en)
|
2022-01-31 |
2024-08-15 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
EP4238988A1
(en)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antibodies against sars-cov-2 and uses thereof
|
GB202204813D0
(en)
|
2022-04-01 |
2022-05-18 |
Bradcode Ltd |
Human monoclonal antibodies and methods of use thereof
|
US20230365708A1
(en)
|
2022-04-01 |
2023-11-16 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
US20230357851A1
(en)
|
2022-04-06 |
2023-11-09 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin-replacement therapy
|
US20230416361A1
(en)
|
2022-04-06 |
2023-12-28 |
Mirobio Limited |
Engineered cd200r antibodies and uses thereof
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023240201A1
(en)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
|
WO2023239710A1
(en)
|
2022-06-08 |
2023-12-14 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones as pi3k inhibitors
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024038160A1
(en)
|
2022-08-18 |
2024-02-22 |
Vib Vzw |
Means and methods to modulate neuron excitability
|
WO2024054469A1
(en)
|
2022-09-08 |
2024-03-14 |
Onkure, Inc. |
Isoquinolones as pi3k inhibitors
|
WO2024064024A1
(en)
|
2022-09-19 |
2024-03-28 |
Onkure, Inc. |
((4-oxo-3,4-dihydroquinazolin-8-yl)methyl)amine derivatives as p13k inhibitors for the treatment of cancer
|
WO2024064002A1
(en)
|
2022-09-20 |
2024-03-28 |
Onkure, Inc. |
Hdac inhibitor oki-179 for the treatment of cancers resulting from a mapk pathway mutation
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
WO2024081345A1
(en)
|
2022-10-14 |
2024-04-18 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones as pi3k inhibitors
|
WO2024078729A1
(en)
|
2022-10-14 |
2024-04-18 |
University College Cork - National University Of Ireland, Cork |
Placenta expressed proteins for use in the treatment of tendon injury
|
WO2024102466A2
(en)
|
2022-11-11 |
2024-05-16 |
Igan Biosciences |
Iga protease polypeptide agents
|
WO2024124041A1
(en)
|
2022-12-07 |
2024-06-13 |
Advanced Cell Diagnostics, Inc. |
Multiplexed detection of nucleic acid targets
|
WO2024178172A1
(en)
|
2023-02-23 |
2024-08-29 |
University Of Rochester |
Agents and methods for making closed-end dna thread molecules
|